Stat6	B-protein
inhibits	O
human	O
interleukin-4	B-DNA
promoter	I-DNA
activity	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

The	O
differentiation	O
of	O
naive	B-cell_type
T-helper	I-cell_type
(	I-cell_type
Th	I-cell_type
)	I-cell_type
cells	I-cell_type
into	O
cytokine-secreting	B-cell_type
effector	I-cell_type
Th	I-cell_type
cells	I-cell_type
requires	O
exposure	O
to	O
multiple	O
signals	O
,	O
including	O
exogenous	B-protein
cytokines	I-protein
.	O

Interleukin-4	B-protein
(	O
IL-4	B-protein
)	O
plays	O
a	O
major	O
role	O
in	O
this	O
process	O
by	O
promoting	O
the	O
differentiation	O
of	O
IL-4	B-protein
-secreting	O
Th2	O
cells	O
.	O

In	O
Th2	O
cells	O
,	O
IL-4	B-protein
gene	O
expression	O
is	O
tightly	O
controlled	O
at	O
the	O
level	O
of	O
transcription	O
by	O
the	O
coordinated	O
binding	O
of	O
multiple	O
transcription	B-protein
factors	I-protein
to	O
regulatory	O
elements	O
in	O
the	O
proximal	O
promoter	B-DNA
region	I-DNA
.	O

Nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cell	I-protein
(	I-protein
NFAT	I-protein
)	I-protein
family	I-protein
members	I-protein
play	O
a	O
critical	O
role	O
in	O
regulating	O
IL-4	B-protein
transcription	O
and	O
interact	O
with	O
up	O
to	O
five	O
sequences	O
(	O
termed	O
P0	O
through	O
P4	O
)	O
in	O
the	O
IL-4	B-DNA
promoter	I-DNA
.	O

The	O
molecular	O
mechanisms	O
by	O
which	O
IL-4	B-protein
induces	O
expression	O
of	O
the	O
IL-4	B-DNA
gene	I-DNA
are	O
not	O
known	O
,	O
although	O
the	O
IL-4-activated	B-protein
transcription	I-protein
factor	I-protein
signal	I-protein
transducer	I-protein
and	I-protein
activator	I-protein
of	I-protein
transcription	I-protein
6	I-protein
(	O
Stat6	B-protein
)	O
is	O
required	O
for	O
this	O
effect	O
.	O

We	O
report	O
here	O
that	O
Stat6	B-protein
interacts	O
with	O
three	O
binding	O
sites	O
in	O
the	O
human	B-DNA
IL-4	I-DNA
promoter	I-DNA
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

These	O
sites	O
overlap	O
the	O
P1	B-DNA
,	I-DNA
P2	I-DNA
,	I-DNA
and	I-DNA
P4	I-DNA
NFAT	I-DNA
elements	I-DNA
.	O

To	O
investigate	O
the	O
role	O
of	O
Stat6	B-protein
in	O
regulating	O
IL-4	B-protein
transcription	O
,	O
we	O
used	O
Stat6	B-protein
-deficient	O
Jurkat	O
T	B-cell_type
cells	I-cell_type
with	O
different	O
intact	O
IL-4	B-DNA
promoter	I-DNA
constructs	I-DNA
in	O
cotransfection	O
assays	O
.	O

We	O
show	O
that	O
,	O
whereas	O
a	O
multimerized	B-DNA
response	I-DNA
element	I-DNA
from	O
the	O
germline	B-DNA
IgE	I-DNA
promoter	I-DNA
was	O
highly	O
induced	O
by	O
IL-4	B-protein
in	O
Stat6-expressing	B-cell_type
Jurkat	I-cell_type
cells	I-cell_type
,	O
the	O
intact	O
human	B-DNA
IL-4	I-DNA
promoter	I-DNA
was	O
repressed	O
under	O
similar	O
conditions	O
.	O

We	O
conclude	O
that	O
the	O
function	O
of	O
Stat6	B-protein
is	O
highly	O
dependent	O
on	O
promoter	O
context	O
and	O
that	O
this	O
factor	O
promotes	O
IL-4	B-protein
gene	O
expression	O
in	O
an	O
indirect	O
manner	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RAPID	NULL
COMMUNICATION	NULL
Stat6	NULL
Inhibits	NULL
Human	NULL
Interleukin-4	NULL
Promoter	NULL
Activity	NULL
in	NULL
T	NULL
Cells	NULL
By	NULL
Steve	NULL
N.	NULL
Georas	NULL
,	NULL
John	NULL
E.	NULL
Cumberland	NULL
,	NULL
Thomas	NULL
F.	NULL
Burke	NULL
,	NULL
Rongbing	NULL
Chen	NULL
,	NULL
Ulrike	NULL
Schindler	NULL
,	NULL
and	NULL
Vincenzo	NULL
Casolaro	NULL
The	NULL
differentiation	NULL
of	NULL
naive	NULL
T-helper	NULL
(	NULL
Th	NULL
)	NULL
cells	NULL
into	NULL
cytokine-secreting	NULL
effector	NULL
Th	NULL
cells	NULL
requires	NULL
exposure	NULL
to	NULL
multiple	NULL
signals	NULL
,	NULL
including	NULL
exogenous	NULL
cytokines	NULL
.	NULL

Interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
this	NULL
process	NULL
by	NULL
promoting	NULL
the	NULL
differentiation	NULL
of	NULL
IL-4-secreting	NULL
Th2	NULL
cells	NULL
.	NULL

In	NULL
Th2	NULL
cells	NULL
,	NULL
IL-4	NULL
gene	NULL
expression	NULL
is	NULL
tightly	NULL
controlled	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
by	NULL
the	NULL
coordinated	NULL
binding	NULL
of	NULL
multiple	NULL
transcription	NULL
factors	NULL
to	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
proximal	NULL
promoter	NULL
region	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cell	NULL
(	NULL
NFAT	NULL
)	NULL
family	NULL
members	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
regulating	NULL
IL-4	NULL
transcription	NULL
and	NULL
interact	NULL
with	NULL
up	NULL
to	NULL
five	NULL
sequences	NULL
(	NULL
termed	NULL
PO	NULL
through	NULL
P4	NULL
)	NULL
in	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
IL-4	NULL
induces	NULL
expression	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
are	NULL
not	NULL
known	NULL
,	NULL
although	NULL
the	NULL
IL-4-activated	NULL
transcription	NULL
factor	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
6	NULL
(	NULL
Stat6	NULL
)	NULL
is	NULL
required	NULL
for	NULL
this	NULL
effect	NULL
.	NULL

NTERLEUKIN-4	NULL
(	NULL
IL-4	NULL
)	NULL
is	NULL
a	NULL
prototypic	NULL
immunoregulatory	NULL
cytokine	NULL
.	NULL

!	NULL

By	NULL
virtue	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
induce	NULL
IgE	NULL
isotype	NULL
switching	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
mast	NULL
cell	NULL
differentiation	NULL
,	NULL
and	NULL
adhesion	NULL
molecule	NULL
expression	NULL
,	NULL
IL-4	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
many	NULL
inflammatory	NULL
responses	NULL
.	NULL
``	NULL

IL-4	NULL
is	NULL
also	NULL
the	NULL
primary	NULL
cytokine	NULL
promoting	NULL
the	NULL
differentiation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
into	NULL
cytokine-secreting	NULL
T-helper	NULL
2	NULL
(	NULL
Th2	NULL
)	NULL
cells	NULL
.	NULL
``	NULL

Cytokine	NULL
gene	NULL
expression	NULL
in	NULL
Th2	NULL
cells	NULL
is	NULL
controlled	NULL
primarily	NULL
at	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
transcription	NULL
,	NULL
°	NULL
and	NULL
dysregulation	NULL
of	NULL
this	NULL
process	NULL
is	NULL
thought	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
development	NULL
of	NULL
allergic	NULL
diseases	NULL
.	NULL
``	NULL

Several	NULL
transcription	NULL
factors	NULL
have	NULL
recently	NULL
been	NULL
implicated	NULL
in	NULL
regulating	NULL
Th2-restricted	NULL
IL-4	NULL
gene	NULL
expression	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

Nuclear	NULL
factors	NULL
of	NULL
activated	NULL
T	NULL
cell	NULL
(	NULL
NFAT	NULL
)	NULL
are	NULL
involved	NULL
in	NULL
this	NULL
process	NULL
by	NULL
interacting	NULL
with	NULL
up	NULL
to	NULL
five	NULL
sites	NULL
in	NULL
the	NULL
IL-4	NULL
promoter	NULL
(	NULL
termed	NULL
PO	NULL
through	NULL
P4	NULL
)	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
The	NULL
precise	NULL
role	NULL
of	NULL
individual	NULL
NFAT	NULL
family	NULL
members	NULL
in	NULL
regulating	NULL
IL-4	NULL
transcription	NULL
is	NULL
currently	NULL
unknown	NULL
.	NULL

!	NULL

*8	NULL
Using	NULL
T-cell	NULL
lines	NULL
derived	NULL
from	NULL
NFAT-reporter	NULL
transgenic	NULL
mice	NULL
,	NULL
Rincon	NULL
and	NULL
Flavell	NULL
``	NULL
found	NULL
that	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
is	NULL
preferentially	NULL
induced	NULL
in	NULL
Th2	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Thl	NULL
cells	NULL
.	NULL

Growing	NULL
evidence	NULL
suggests	NULL
that	NULL
Th2-specific	NULL
NFAT	NULL
cofactors	NULL
may	NULL
specifically	NULL
enhance	NULL
IL-4	NULL
transcription	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Ho	NULL
et	NULL
al	NULL
``	NULL
found	NULL
that	NULL
the	NULL
proto-oncogene	NULL
c-maf	NULL
was	NULL
preferentially	NULL
expressed	NULL
in	NULL
Th2	NULL
clones	NULL
and	NULL
that	NULL
c-Maf	NULL
acts	NULL
synergistically	NULL
with	NULL
NFATp	NULL
to	NULL
induce	NULL
IL-4	NULL
production	NULL
in	NULL
IL-4-negative	NULL
cells	NULL
.	NULL

Additionally	NULL
,	NULL
Li-Weber	NULL
et	NULL
al	NULL
``	NULL
detected	NULL
a	NULL
multiprotein	NULL
complex	NULL
containing	NULL
C/EBP	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
AP-1	NULL
proteins	NULL
forming	NULL
on	NULL
the	NULL
P4	NULL
element	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
Th2	NULL
but	NULL
not	NULL
Th1	NULL
cells	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Exogenous	NULL
IL-4	NULL
is	NULL
a	NULL
critical	NULL
stimulus	NULL
for	NULL
the	NULL
effective	NULL
differentiation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
into	NULL
IL-4-secreting	NULL
Th2	NULL
cells	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
O'Garra	NULL
'	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
IL-4	NULL
induces	NULL
expression	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
is	NULL
currently	NULL
not	NULL
known	NULL
.	NULL

IL-4	NULL
interacts	NULL
with	NULL
a	NULL
multichain	NULL
cell-surface	NULL
receptor	NULL
(	NULL
IL-4R	NULL
)	NULL
that	NULL
is	NULL
expressed	NULL
by	NULL
several	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
B	NULL
cells	NULL
,	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
endothelial	NULL
cells.4	NULL
``	NULL
``	NULL
IL-4	NULL
binding	NULL
to	NULL
the	NULL
IL-4Ra	NULL
chain	NULL
induces	NULL
different	NULL
intracellular	NULL
signals	NULL
,	NULL
including	NULL
Jak-mediated	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Stat6	NULL
.	NULL
``	NULL

''	NULL
Stat6	NULL
response	NULL
elements	NULL
share	NULL
a	NULL
consensus	NULL
sequence	NULL
*	NULL
TTCN34GAA®*	NULL
``	NULL
and	NULL
are	NULL
Blood	NULL
,	NULL
Vol	NULL
92	NULL
,	NULL
No	NULL
12	NULL
(	NULL
December	NULL
15	NULL
)	NULL
,	NULL
1998	NULL
:	NULL
pp	NULL
4529-4538	NULL
We	NULL
report	NULL
here	NULL
that	NULL
Stat6	NULL
interacts	NULL
with	NULL
three	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
IL-4	NULL
promoter	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

These	NULL
sites	NULL
overlap	NULL
the	NULL
P1	NULL
,	NULL
P2	NULL
,	NULL
and	NULL
P4	NULL
NFAT	NULL
elements	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
regulating	NULL
IL-4	NULL
transcription	NULL
,	NULL
we	NULL
used	NULL
Staté-deficient	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
different	NULL
intact	NULL
IL-4	NULL
promoter	NULL
constructs	NULL
in	NULL
cotransfection	NULL
assays	NULL
.	NULL

We	NULL
show	NULL
that	NULL
,	NULL
whereas	NULL
a	NULL
multimerized	NULL
response	NULL
element	NULL
from	NULL
the	NULL
germline	NULL
IgE	NULL
promoter	NULL
was	NULL
highly	NULL
induced	NULL
by	NULL
IL-4	NULL
in	NULL
Stat6-expressing	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
intact	NULL
human	NULL
IL-4	NULL
promoter	NULL
was	NULL
repressed	NULL
under	NULL
similar	NULL
conditions	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
function	NULL
of	NULL
Stat6	NULL
is	NULL
highly	NULL
dependent	NULL
on	NULL
promoter	NULL
context	NULL
and	NULL
that	NULL
this	NULL
factor	NULL
promotes	NULL
IL-4	NULL
gene	NULL
expression	NULL
in	NULL
an	NULL
indirect	NULL
manner	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

located	NULL
in	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
many	NULL
IL-4-responsive	NULL
genes	NULL
.	NULL
``	NULL

The	NULL
fundamental	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
IL-4-driven	NULL
responses	NULL
was	NULL
demonstrated	NULL
by	NULL
the	NULL
phenotype	NULL
of	NULL
Stat6-deficient	NULL
mice	NULL
in	NULL
which	NULL
IgE	NULL
synthesis	NULL
and	NULL
Th2	NULL
responses	NULL
were	NULL
abro-gated	NULL
.	NULL
``	NULL

Lederer	NULL
et	NULL
al	NULL
``	NULL
!	NULL

discovered	NULL
a	NULL
Stat6	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
mouse	NULL
IL-4	NULL
promoter	NULL
and	NULL
found	NULL
that	NULL
Stat6é	NULL
bound	NULL
this	NULL
sequence	NULL
in	NULL
EMSA	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
IL-4	NULL
induced	NULL
Th2	NULL
cells	NULL
but	NULL
not	NULL
Th1	NULL
cells	NULL
.	NULL

We	NULL
and	NULL
others	NULL
identified	NULL
a	NULL
corresponding	NULL
site	NULL
in	NULL
the	NULL
human	NULL
IL-4	NULL
promoter	NULL
(	NULL
~'®TTCACAGGAA~	NULL
!	NULL

,	NULL
.	NULL

``	NULL
%	NULL
``	NULL
``	NULL
Because	NULL
multimers	NULL
of	NULL
these	NULL
elements	NULL
were	NULL
inducible	NULL
by	NULL
IL-4	NULL
when	NULL
linked	NULL
to	NULL
heterologous	NULL
promoters	NULL
and	NULL
transfected	NULL
into	NULL
Staté-expressing	NULL
B-cell	NULL
lines	NULL
,	NULL
``	NULL
``	NULL
it	NULL
seemed	NULL
reasonable	NULL
to	NULL
conclude	NULL
that	NULL
Stat6	NULL
would	NULL
directly	NULL
enhance	NULL
IL-4	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
activation	NULL
of	NULL
IL-4R	NULL
signaling	NULL
pathways	NULL
is	NULL
not	NULL
required	NULL
for	NULL
IL-4	NULL
gene	NULL
expression	NULL
in	NULL
effector	NULL
T	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Huang	NULL
et	NULL
al	NULL
``	NULL
``	NULL
found	NULL
that	NULL
IL-4	NULL
did	NULL
not	NULL
enhance	NULL
transcription	NULL
driven	NULL
by	NULL
a	NULL
mouse	NULL
IL-4	NULL
promoter	NULL
construct	NULL
in	NULL
anti-CD3-activated	NULL
Th2	NULL
cells	NULL
,	NULL
although	NULL
the	NULL
specific	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
regulating	NULL
the	NULL
intact	NULL
IL-4	NULL
promoter	NULL
was	NULL
not	NULL
examined	NULL
in	NULL
that	NULL
study	NULL
.	NULL

Additionally	NULL
,	NULL
Morigg	NULL
!	NULL

et	NULL
al	NULL
``	NULL
reported	NULL
that	NULL
a	NULL
neutralizing	NULL
anti-IL-4	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MoAb	NULL
)	NULL
actually	NULL
enhanced	NULL
anti-CD3-induced	NULL
IL-4	NULL
production	NULL
From	NULL
the	NULL
Divisions	NULL
of	NULL
Pulmonary	NULL
and	NULL
Critical	NULL
Care	NULL
Medicine	NULL
and	NULL
Allergy	NULL
and	NULL
Clinical	NULL
Immunology	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
Asthma	NULL
and	NULL
Allergy	NULL
Center	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
;	NULL
and	NULL
Tularik	NULL
Inc	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
.	NULL

Submitted	NULL
July	NULL
2	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
October	NULL
5	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
by	NULL
Grant	NULL
No	NULL
.	NULL

AIO1152	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
and	NULL
Research	NULL
Grant	NULL
No	NULL
.	NULL

O56-N	NULL
from	NULL
the	NULL
American	NULL
Lung	NULL
Association	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Steve	NULL
N.	NULL
Georas	NULL
,	NULL
MD	NULL
,	NULL
Room	NULL
4B.41	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
Asthma	NULL
&	NULL
Allergy	NULL
Center	NULL
,	NULL
5501	NULL
Hopkins	NULL
Bayview	NULL
Circle	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
21224	NULL
;	NULL
e-mail	NULL
:	NULL
sgeoras	NULL
@	NULL
welchlink.welch.jhu.edu	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/98/9212-0046	NULL
$	NULL
3.00/0	NULL
4529	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4530	NULL
NﬁAT	NULL
NTAT	NULL
NTAT	NULL
NFAT	NULL
GEORAS	NULL
ET	NULL
AL	NULL
--	NULL
-	NULL
Fig	NULL
1	NULL
.	NULL

The	NULL
proximal	NULL
IL-4	NULL
promoter	NULL
(	NULL
not	NULL
draw	NULL
n	NULL
to	NULL
scale	NULL
)	NULL
.	NULL

NFAT	NULL
binding	NULL
sites	NULL
(	NULL
the	NULL
P	NULL
elements	NULL
)	NULL
NFAT	NULL
+	NULL
!	NULL

are	NULL
indicated	NULL
by	NULL
open	NULL
boxes	NULL
,	NULL
and	NULL
PO	NULL
|	NULL
the	NULL
know	NULL
n	NULL
Stat6	NULL
site	NULL
is	NULL
indicated	NULL
300	NULL
-100	NULL
|	NULL
PA	NULL
P3	NULL
P1	NULL
by	NULL
the	NULL
solid	NULL
box	NULL
.	NULL

Transcription	NULL
I	NULL
factors	NULL
implicated	NULL
in	NULL
Th2-specific	NULL
IL-4	NULL
gene	NULL
expression	NULL
are	NULL
in	NULL
C/EBPY,5	NULL
Stat6	NULL
``	NULL
Activated	NULL
``	NULL
-	NULL
c-Maf	NULL
dicated	NULL
below	NULL
their	NULL
respective	NULL
NFAT	NULL
NFAT	NULL
binding	NULL
sites	NULL
.	NULL

A	NULL
binding	NULL
site	NULL
for	NULL
c-Jun	NULL
GATA-3	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
re	NULL
ported	NULL
.	NULL
``	NULL

NFAT	NULL
activity	NULL
is	NULL
higher	NULL
7	NULL
?	NULL

other	NULL
\	NULL
T	NULL
/	NULL
in	NULL
effector	NULL
Th	NULL
cells	NULL
(	NULL
``	NULL
Activated	NULL
``	NULL
``	NULL
NFAT	NULL
)	NULL
and	NULL
is	NULL
show	NULL
n	NULL
for	NULL
simplic-A	NULL
ity	NULL
binding	NULL
only	NULL
to	NULL
the	NULL
P1	NULL
NFAT	NULL
GATA-3	NULL
site	NULL
.	NULL

in	NULL
committed	NULL
Th2	NULL
cells	NULL
.	NULL

Using	NULL
Stat6-deficient	NULL
Jurkat	NULL
T	NULL
cells	NULL
in	NULL
cotransfection	NULL
assays	NULL
,	NULL
we	NULL
report	NULL
here	NULL
that	NULL
,	NULL
although	NULL
cotransfected	NULL
Stat6	NULL
strongly	NULL
enhanced	NULL
transcription	NULL
driven	NULL
by	NULL
a	NULL
multimerized	NULL
response	NULL
element	NULL
,	NULL
the	NULL
human	NULL
IL-4	NULL
promoter	NULL
was	NULL
significantly	NULL
repressed	NULL
under	NULL
similar	NULL
conditions	NULL
.	NULL

The	NULL
repressive	NULL
effects	NULL
of	NULL
Stat6	NULL
appeared	NULL
to	NULL
involve	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
,	NULL
because	NULL
a	NULL
Staté	NULL
DNA	NULL
binding	NULL
domain	NULL
mutant	NULL
failed	NULL
to	NULL
inhibit	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

We	NULL
describe	NULL
two	NULL
novel	NULL
Stat6	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
proximal	NULL
IL-4	NULL
promoter	NULL
and	NULL
show	NULL
that	NULL
Stat6	NULL
and	NULL
NEAT	NULL
bind	NULL
competitively	NULL
to	NULL
overlapping	NULL
nucleotides	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmid	NULL
construction	NULL
.	NULL

IL-4	NULL
promoter	NULL
constructs	NULL
were	NULL
amplified	NULL
from	NULL
human	NULL
genomic	NULL
DNA	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
.	NULL

A	NULL
25-bp	NULL
5	NULL
'	NULL
primer	NULL
annealing	NULL
265	NULL
bp	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
tss	NULL
)	NULL
according	NULL
to	NULL
Otsuka	NULL
et	NULL
al	NULL
``	NULL
``	NULL
was	NULL
used	NULL
with	NULL
a	NULL
25-bp	NULL
3	NULL
'	NULL
primer	NULL
ending	NULL
at	NULL
position	NULL
+65	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
sequenced	NULL
using	NULL
the	NULL
dideoxy	NULL
method	NULL
and	NULL
then	NULL
ligated	NULL
into	NULL
the	NULL
HindIH	NULL
and	NULL
Xba	NULL
I	NULL
sites	NULL
of	NULL
pCAT	NULL
Basic	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
to	NULL
yield	NULL
pCAT	NULL
265	NULL
.	NULL

The	NULL
reporter	NULL
C/EBP-N4	NULL
luc	NULL
contains	NULL
4	NULL
copies	NULL
of	NULL
the	NULL
composite	NULL
C/EBP/Stat6	NULL
response	NULL
element	NULL
from	NULL
the	NULL
germline	NULL
e	NULL
promoter	NULL
fused	NULL
to	NULL
a	NULL
thymidine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
minimal	NULL
promoter	NULL
driving	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
.	NULL

*	NULL
``	NULL
The	NULL
wild-type	NULL
Stat6	NULL
expression	NULL
vector	NULL
(	NULL
TPU	NULL
388	NULL
)	NULL
and	NULL
the	NULL
DNA-binding	NULL
domain	NULL
mutant	NULL
vector	NULL
(	NULL
TPUS22	NULL
,	NULL
in	NULL
which	NULL
the	NULL
3	NULL
amino	NULL
acids	NULL
VVI	NULL
at	NULL
positions	NULL
411	NULL
to	NULL
413	NULL
were	NULL
replaced	NULL
by	NULL
EAA	NULL
)	NULL
,	NULL
both	NULL
driven	NULL
by	NULL
the	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
promoter	NULL
,	NULL
have	NULL
been	NULL
described	NULL
.	NULL
``	NULL

Cell	NULL
lines	NULL
and	NULL
transfections	NULL
.	NULL

-	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
Jack	NULL
Strominger	NULL
,	NULL
Harvard	NULL
University	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
complete	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
[	NULL
FCS	NULL
;	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
]	NULL
and	NULL
50	NULL
ug/mL	NULL
gentamycin	NULL
[	NULL
Life	NULL
Technologies	NULL
]	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
,	NULL
these	NULL
cells	NULL
constitutively	NULL
express	NULL
IL-4	NULL
mRNA	NULL
.	NULL

``	NULL
!	NULL

HepG2	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
ATCC	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
DMEM	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
50	NULL
ug/mL	NULL
gentamycin	NULL
.	NULL

In	NULL
cotransfection	NULL
experiments	NULL
,	NULL
3	NULL
X	NULL
106	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
ug	NULL
reporter	NULL
,	NULL
2	NULL
ug	NULL
expression	NULL
or	NULL
empty	NULL
vector	NULL
as	NULL
a	NULL
control	NULL
,	NULL
and	NULL
7	NULL
uL	NULL
Superfect	NULL
(	NULL
Qiagen	NULL
,	NULL
Valencia	NULL
,	NULL
CA	NULL
)	NULL
in	NULL
5	NULL
mL	NULL
complete	NULL
medium	NULL
and	NULL
allowed	NULL
to	NULL
recover	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
combinations	NULL
of	NULL
the	NULL
following	NULL
agonists	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
text	NULL
for	NULL
the	NULL
last	NULL
18	NULL
hours	NULL
:	NULL
1	NULL
umol/L	NULL
calcium	NULL
ionophore	NULL
(	NULL
A23187	NULL
;	NULL
Calbiochem	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
25	NULL
ng/mL	NULL
phorbol-12-myristate-13-acetate	NULL
(	NULL
PMA	NULL
;	NULL
Calbiochem	NULL
)	NULL
,	NULL
and	NULL
IL-4	NULL
(	NULL
10	NULL
or	NULL
50	NULL
ng/mL	NULL
;	NULL
Peprotech	NULL
,	NULL
Rocky	NULL
Hill	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
by	NULL
three	NULL
freeze-thaw	NULL
cycles	NULL
and	NULL
reporter	NULL
gene	NULL
expression	NULL
was	NULL
determined	NULL
either	NULL
by	NULL
measuring	NULL
CAT	NULL
enzyme	NULL
levels	NULL
using	NULL
a	NULL
sensitive	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
;	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
or	NULL
by	NULL
assaying	NULL
for	NULL
luciferase	NULL
activity	NULL
using	NULL
standard	NULL
techniques	NULL
(	NULL
Analytic	NULL
Luminescence	NULL
Laboratories	NULL
,	NULL
Sparks	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
normalized	NULL
for	NULL
protein	NULL
content	NULL
using	NULL
the	NULL
Bradford	NULL
technique	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
before	NULL
assays	NULL
for	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

EMSA	NULL
.	NULL

-	NULL
The	NULL
following	NULL
30-bp	NULL
oligonucleotides	NULL
and	NULL
their	NULL
complements	NULL
were	NULL
synthesized	NULL
(	NULL
mutations	NULL
in	NULL
the	NULL
P2	NULL
oligonucleotide	NULL
are	NULL
indicated	NULL
as	NULL
lowercase	NULL
letters	NULL
,	NULL
and	NULL
the	NULL
Staté	NULL
consensus	NULL
sequence	NULL
is	NULL
underlined	NULL
)	NULL
:	NULL
5'-ATTGCTGAAACCGAGGGAAAATGAGTTITACAT-	NULL
TG-3	NULL
'	NULL
(	NULL
PO	NULL
-69	NULL
to	NULL
-36	NULL
)	NULL
;	NULL
5	NULL
``	NULL
-TGAGTTTACATTGGAAATTTTCGTTACACCAGATTG-3	NULL
'	NULL
(	NULL
P1	NULL
=92	NULL
to	NULL
-60	NULL
)	NULL
,	NULL
(	NULL
P2	NULL
wt	NULL
-175	NULL
to	NULL
-146	NULL
)	NULL
;	NULL
5'-gagac-TTTCACAGGAACATTITACCTGTTT3	NULL
'	NULL
(	NULL
P2	NULL
ml	NULL
)	NULL
;	NULL
5'-TCTGAgggacCAGGAACATTTTACCTGTITT3	NULL
'	NULL
(	NULL
P2	NULL
m2	NULL
)	NULL
;	NULL
5'-TCTGATTTCAgetegACATTITACCTGTTT3	NULL
'	NULL
(	NULL
P2	NULL
m3	NULL
)	NULL
;	NULL
5'-TCT-GATTTCACAGGActeggTTACCTGTTT-3	NULL
'	NULL
(	NULL
P2	NULL
m4	NULL
)	NULL
;	NULL
5	NULL
``	NULL
-TCTGATTTCA-CAGGAACATTTIgegtt-TGTTT-3	NULL
'	NULL
(	NULL
P2	NULL
m5	NULL
)	NULL
;	NULL
5	NULL
``	NULL
-TCTGATTITCACAGGAA-CATTTTTACCcaceg-3	NULL
'	NULL
(	NULL
P2	NULL
m6	NULL
)	NULL
;	NULL
5-AATCAGACCAATAGGAAAA-TGAAACCITTITTTAA-3	NULL
'	NULL
(	NULL
P3	NULL
-201	NULL
to	NULL
-169	NULL
)	NULL
;	NULL
and	NULL
5-AGTITCAGCATAG-GAAATTACACCATAATTITTGC-3	NULL
'	NULL
(	NULL
P4	NULL
-248	NULL
to	NULL
-216	NULL
)	NULL
.	NULL

The	NULL
Bcel-6	NULL
oligonucleotide	NULL
(	NULL
B6BS	NULL
:	NULL
5'-GAAAATTCCTAGAAAG-CATA-3	NULL
'	NULL
;	NULL
donated	NULL
by	NULL
Dr	NULL
Riccardo	NULL
Dalla-Favera	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
has	NULL
been	NULL
described	NULL
.	NULL
``	NULL

Nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
from	NULL
5	NULL
X	NULL
10°	NULL
Jurkat	NULL
cells	NULL
treated	NULL
without	NULL
or	NULL
with	NULL
IL-4	NULL
(	NULL
20	NULL
ng/mL	NULL
for	NULL
20	NULL
minutes	NULL
;	NULL
Peprotech	NULL
)	NULL
using	NULL
the	NULL
method	NULL
of	NULL
Schrieber	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
EMSAs	NULL
were	NULL
performed	NULL
using	NULL
5	NULL
ug	NULL
nuclear	NULL
protein	NULL
,	NULL
0.8	NULL
ug	NULL
poly	NULL
(	NULL
dG-dC	NULL
)	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
and	NULL
[	NULL
y°P	NULL
]	NULL
end-labeled	NULL
probe	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
10	NULL
uL	NULL
per	NULL
reaction	NULL
.	NULL

Free	NULL
probes	NULL
and	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
with	NULL
0.5X	NULL
TBE	NULL
.	NULL

In	NULL
antibody	NULL
experiments	NULL
,	NULL
extracts	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
1	NULL
uL	NULL
of	NULL
the	NULL
following	NULL
antisera	NULL
for	NULL
30	NULL
minutes	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
labeled	NULL
probe	NULL
:	NULL
anti-Stat6	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotech	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
N70-6	NULL
(	NULL
anti-Bel-6*	NULL
;	NULL
donated	NULL
by	NULL
Dr	NULL
Riccardo	NULL
Dalla-Favera	NULL
)	NULL
,	NULL
or	NULL
isotype-matched	NULL
control	NULL
antisera	NULL
.	NULL

Recombinant	NULL
proteins	NULL
.	NULL

-	NULL
A	NULL
recombinant	NULL
fragment	NULL
of	NULL
murine	NULL
NFATp	NULL
(	NULL
including	NULL
298	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
[	NULL
DBD	NULL
]	NULL
that	NULL
is	NULL
highly	NULL
conserved	NULL
among	NULL
different	NULL
NFAT	NULL
family	NULL
members	NULL
)	NULL
was	NULL
expressed	NULL
as	NULL
a	NULL
hexahistidine-tagged	NULL
protein	NULL
and	NULL
extracted	NULL
as	NULL
described	NULL
.	NULL
``	NULL

The	NULL
NFATp	NULL
expression	NULL
vector	NULL
was	NULL
kindly	NULL
donated	NULL
by	NULL
Dr	NULL
Anjana	NULL
Rao	NULL
(	NULL
Harvard	NULL
University	NULL
)	NULL
.	NULL

Recombinant	NULL
full-length	NULL
,	NULL
in	NULL
vitro	NULL
phosphorylated	NULL
Stat6	NULL
has	NULL
been	NULL
described	NULL
.	NULL
``	NULL

Statistical	NULL
analysis	NULL
.	NULL

-	NULL
All	NULL
transfections	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
using	NULL
cells	NULL
of	NULL
similar	NULL
passage	NULL
number	NULL
.	NULL

Average	NULL
results	NULL
of	NULL
the	NULL
indicated	NULL
numbers	NULL
of	NULL
independent	NULL
experiments	NULL
were	NULL
analyzed	NULL
using	NULL
the	NULL
paired	NULL
Student	NULL
's	NULL
+test	NULL
(	NULL
Statview	NULL
II	NULL
Software	NULL
;	NULL
SAS	NULL
Institute	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
a	NULL
P	NULL
value	NULL
less	NULL
than	NULL
.05	NULL
was	NULL
considered	NULL
to	NULL
be	NULL
statistically	NULL
significant	NULL
.	NULL

RESULTS	NULL
The	NULL
IL-4R	NULL
signaling	NULL
pathway	NULL
is	NULL
intact	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
regulating	NULL
transcription	NULL
of	NULL
the	NULL
intact	NULL
IL-4	NULL
promoter	NULL
,	NULL
we	NULL
studied	NULL
Jurkat	NULL
T	NULL
cells	NULL
transiently	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Stat6	NULL
INHIBITS	NULL
THE	NULL
INTERLEUKIN-4	NULL
PROMOTER	NULL
transfected	NULL
with	NULL
different	NULL
IL-4	NULL
promoter	NULL
reporter	NULL
constructs	NULL
.	NULL

In	NULL
preliminary	NULL
experiments	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
immunoreactive	NULL
Stat6	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
IL-4-activated	NULL
Jurkat	NULL
cells	NULL
in	NULL
EMSA	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
cells	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
express	NULL
negligible	NULL
levels	NULL
of	NULL
this	NULL
factor	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
result	NULL
,	NULL
IL-4	NULL
stimulation	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
a	NULL
full-length	NULL
IL-4	NULL
promoter	NULL
construct	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
or	NULL
the	NULL
reporter	NULL
construct	NULL
C/EBP-N4	NULL
lue	NULL
(	NULL
which	NULL
contains	NULL
4	NULL
copies	NULL
of	NULL
the	NULL
IgE	NULL
C/EBP/Stat6	NULL
element	NULL
driving	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
;	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
,	NULL
``	NULL
C/EBP-N4	NULL
luc	NULL
was	NULL
strongly	NULL
induced	NULL
by	NULL
IL-4	NULL
in	NULL
Staté-expressing	NULL
HepG2	NULL
cells	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
the	NULL
IL-4R	NULL
signaling	NULL
pathway	NULL
was	NULL
otherwise	NULL
functional	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
we	NULL
first	NULL
analyzed	NULL
the	NULL
inducibility	NULL
of	NULL
C/EBP-N4	NULL
luc	NULL
in	NULL
cells	NULL
cotransfected	NULL
with	NULL
a	NULL
full-length	NULL
Stat6	NULL
expression	NULL
vector	NULL
.	NULL

Activity	NULL
of	NULL
C/EBP-N4	NULL
luc	NULL
is	NULL
strongly	NULL
dependent	NULL
on	NULL
the	NULL
coordinated	NULL
binding	NULL
of	NULL
C/EBP	NULL
and	NULL
Stat6	NULL
to	NULL
adjacent	NULL
sites	NULL
.	NULL
``	NULL

''	NULL
Figure	NULL
2A	NULL
shows	NULL
that	NULL
C/EBP-N4	NULL
luc	NULL
was	NULL
highly	NULL
induced	NULL
by	NULL
IL-4	NULL
in	NULL
Stat6-expressing	NULL
Jurkat	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
control	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
corresponding	NULL
empty	NULL
vector	NULL
.	NULL

This	NULL
result	NULL
confirms	NULL
the	NULL
known	NULL
expression	NULL
of	NULL
C/EBP	NULL
proteins	NULL
by	NULL
Jurkat	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
Consistent	NULL
with	NULL
previous	NULL
findings	NULL
,	NULL
``	NULL
C/EBP-N4	NULL
lue	NULL
was	NULL
induced	NULL
by	NULL
IL-4	NULL
in	NULL
HepG2	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
exogenous	NULL
Stat6	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
Jurkat	NULL
cells	NULL
do	NULL
not	NULL
constitutively	NULL
express	NULL
functional	NULL
Stat6	NULL
protein	NULL
,	NULL
cotransfected	NULL
Stat6	NULL
is	NULL
highly	NULL
induced	NULL
by	NULL
IL-4	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

IgE	NULL
cs	NULL
4531	NULL
Stat6	NULL
represses	NULL
transcription	NULL
driven	NULL
by	NULL
the	NULL
intact	NULL
IL-4	NULL
promoter	NULL
.	NULL

-	NULL
We	NULL
next	NULL
analyzed	NULL
the	NULL
ability	NULL
of	NULL
Stat6	NULL
to	NULL
transactivate	NULL
the	NULL
intact	NULL
IL-4	NULL
promoter	NULL
.	NULL

Figure	NULL
3	NULL
shows	NULL
that	NULL
a	NULL
full-length	NULL
human	NULL
IL-4	NULL
promoter	NULL
construct	NULL
(	NULL
pCAT	NULL
265	NULL
)	NULL
was	NULL
consistently	NULL
inhibited	NULL
by	NULL
IL-4	NULL
in	NULL
Stat6-cotransfected	NULL
Jurkat	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
lacked	NULL
an	NULL
activation-induced	NULL
Stat6	NULL
cofactor	NULL
or	NULL
whether	NULL
Stat6é	NULL
needed	NULL
a	NULL
further	NULL
activation	NULL
signal	NULL
,	NULL
which	NULL
is	NULL
necessary	NULL
for	NULL
IL-4	NULL
transcription	NULL
,	NULL
we	NULL
next	NULL
analyzed	NULL
the	NULL
effects	NULL
of	NULL
IL-4	NULL
in	NULL
activated	NULL
cells	NULL
cotransfected	NULL
with	NULL
Stat6	NULL
and	NULL
pCAT	NULL
265	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
,	NULL
``	NULL
``	NULL
``	NULL
``	NULL
a	NULL
calcium-dependent	NULL
signal	NULL
alone	NULL
was	NULL
sufficient	NULL
to	NULL
maximally	NULL
induce	NULL
the	NULL
IL-4	NULL
promoter	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

PMA	NULL
downregulated	NULL
IL-4	NULL
promoter	NULL
activity	NULL
,	NULL
which	NULL
we	NULL
previously	NULL
found	NULL
was	NULL
due	NULL
to	NULL
the	NULL
displacement	NULL
of	NULL
NFATp	NULL
from	NULL
the	NULL
human	NULL
P1	NULL
sequence	NULL
by	NULL
induced	NULL
nuclear	NULL
NF-kB	NULL
heterodimers	NULL
.	NULL
``	NULL

Interestingly	NULL
,	NULL
IL-4	NULL
consistently	NULL
inhibited	NULL
calcium-induced	NULL
promoter	NULL
activity	NULL
in	NULL
Stat6-cotransfected	NULL
cells	NULL
and	NULL
almost	NULL
completely	NULL
repressed	NULL
the	NULL
promoter	NULL
in	NULL
combination	NULL
with	NULL
PMA	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
even	NULL
in	NULL
conjunction	NULL
with	NULL
activation	NULL
of	NULL
intracellular	NULL
calcium	NULL
and	NULL
PKC-signaling	NULL
pathways	NULL
,	NULL
Stat6	NULL
inhibited	NULL
transcription	NULL
driven	NULL
by	NULL
the	NULL
full-length	NULL
IL-4	NULL
promoter	NULL
.	NULL

To	NULL
map	NULL
the	NULL
IL-4	NULL
promoter	NULL
element	NULL
(	NULL
s	NULL
)	NULL
necessary	NULL
for	NULL
Stat6-mediated	NULL
transcriptional	NULL
repression	NULL
,	NULL
we	NULL
used	NULL
a	NULL
smaller	NULL
promoter	NULL
construct	NULL
in	NULL
additional	NULL
cotransfection	NULL
experiments	NULL
.	NULL

This	NULL
construct	NULL
(	NULL
pCAT	NULL
145	NULL
)	NULL
contains	NULL
145	NULL
bp	NULL
of	NULL
the	NULL
human	NULL
promoter	NULL
,	NULL
including	NULL
the	NULL
P1	NULL
and	NULL
PO	NULL
NFAT	NULL
elements	NULL
,	NULL
but	NULL
lacks	NULL
the	NULL
previ-	NULL
Reporter	NULL
:	NULL
(	NULL
CIEBP-Staté	NULL
)	NULL
|-	NULL
-	NULL
A.	NULL
Jurkat	NULL
50,0007	NULL
D	NULL
L	NULL
IL	NULL
'	NULL
4	NULL
r	NULL
50,000	NULL
E	NULL
H	NULL
+	NULL
IL-4	NULL
=	NULL
40,000	NULL
|-	NULL
40,000	NULL
=	NULL
r-p	NULL
39.0001	NULL
|	NULL
30,000	NULL
S	NULL
o	NULL
.	NULL

>	NULL
20,000	NULL
|	NULL
20,000	NULL
uud	NULL
S	NULL
pd	NULL
m	NULL
10,0007	NULL
-	NULL
10,000	NULL
07	NULL
a=	NULL
-O	NULL
-Empty-	NULL
_-	NULL
Staté	NULL
Fold	NULL
Induction	NULL
:	NULL
0.4	NULL
94.6	NULL
B.	NULL
Hep	NULL
G2	NULL
150,000	NULL
7	NULL
-	NULL
4,000,000	NULL
100,000	NULL
--	NULL
3,000,000	NULL
-	NULL
2,000,000	NULL
50,000	NULL
--	NULL
1,000,000	NULL
0~	NULL
-	NULL
0	NULL
--	NULL
Empty-	NULL
__	NULL
!	NULL

-	NULL
Staté	NULL
-	NULL
5,000,000	NULL
18.9	NULL
43.6	NULL
Fig	NULL
2	NULL
.	NULL

The	NULL
IL-4	NULL
receptor	NULL
signaling	NULL
pathway	NULL
is	NULL
intact	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
luciferase	NULL
reporter	NULL
construct	NULL
C/EBP-N4	NULL
luc	NULL
(	NULL
see	NULL
text	NULL
)	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
together	NULL
with	NULL
a	NULL
control	NULL
(	NULL
Empty	NULL
)	NULL
or	NULL
Stat6	NULL
expression	NULL
vector	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
stimulated	NULL
without	NULL
(	NULL
0	NULL
)	NULL
or	NULL
with	NULL
(	NULL
MI	NULL
)	NULL
IL-4	NULL
(	NULL
50	NULL
ng/	NULL
mL	NULL
)	NULL
for	NULL
18	NULL
hours	NULL
before	NULL
assays	NULL
for	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
either	NULL
cotransfected	NULL
Stat6	NULL
or	NULL
IL-4	NULL
stimulation	NULL
,	NULL
C/	NULL
EBP-N4	NULL
luc	NULL
is	NULL
not	NULL
active	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
but	NULL
it	NULL
is	NULL
highly	NULL
inducible	NULL
by	NULL
IL-4	NULL
in	NULL
cells	NULL
expressing	NULL
Stat6	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Consistent	NULL
with	NULL
the	NULL
know	NULL
n	NULL
expression	NULL
of	NULL
Stat6	NULL
by	NULL
Hep	NULL
G2	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
C/	NULL
EBP-N4	NULL
lue	NULL
was	NULL
induced	NULL
by	NULL
IL-4	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
but	NULL
its	NULL
activity	NULL
was	NULL
further	NULL
increased	NULL
by	NULL
overexpressing	NULL
Stat6	NULL
(	NULL
note	NULL
the	NULL
different	NULL
scales	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
tw	NULL
o	NULL
(	NULL
B	NULL
)	NULL
or	NULL
three	NULL
(	NULL
A	NULL
)	NULL
independent	NULL
experiments	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4532	NULL
GEORAS	NULL
ET	NULL
AL	NULL
pCAT	NULL
265	NULL
:	NULL
2	NULL
-	NULL
[	NULL
pi	NULL
}	NULL
-pol	NULL
*1	NULL
[	NULL
G6	NULL
-	NULL
IL-4	NULL
M	NULL
+	NULL
IL-4	NULL
_|	NULL
Relative	NULL
CAT	NULL
Activity	NULL
o	NULL
lrk	NULL
T.	NULL
Fig	NULL
3	NULL
.	NULL

Stat6	NULL
inhibits	NULL
transcription	NULL
driven	NULL
by	NULL
the	NULL
intact	NULL
IL-4	NULL
promoter	NULL
.	NULL

pCAT	NULL
265	NULL
,	NULL
which	NULL
contains	NULL
all	NULL
of	NULL
the	NULL
know	NULL
n	NULL
NFAT	NULL
P	NULL
elements	NULL
including	NULL
the	NULL
P2	NULL
Stat6	NULL
site	NULL
(	NULL
solid	NULL
box	NULL
)	NULL
,	NULL
was	NULL
transfected	NULL
into	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
together	NULL
with	NULL
a	NULL
control	NULL
(	NULL
Empty	NULL
)	NULL
or	NULL
a	NULL
Stat6	NULL
expression	NULL
vector	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
incu-	NULL
0	NULL
Expression	NULL
Vector	NULL
:	NULL
-	NULL
Empty	NULL
ously	NULL
described	NULL
Stat6	NULL
binding	NULL
site	NULL
(	NULL
'*®TTCACAGGAA~	NULL
!	NULL

``	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
pCAT145	NULL
activity	NULL
was	NULL
significantly	NULL
inhibited	NULL
by	NULL
IL-4	NULL
in	NULL
both	NULL
resting	NULL
and	NULL
stimulated	NULL
Stat6	NULL
cotransfected	NULL
cells	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
an	NULL
expression	NULL
vector	NULL
encoding	NULL
a	NULL
Stat6	NULL
DNA	NULL
binding	NULL
domain	NULL
mutant	NULL
(	NULL
TPUS22	NULL
,	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
did	NULL
not	NULL
inhibit	NULL
pCAT145	NULL
activity	NULL
in	NULL
either	NULL
resting	NULL
or	NULL
activated	NULL
cells	NULL
(	NULL
Fig	NULL
5	NULL
,	NULL
right	NULL
side	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
Stat6-induced	NULL
repression	NULL
involved	NULL
binding	NULL
sites	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
known	NULL
Stat6	NULL
sequence	NULL
and	NULL
that	NULL
the	NULL
DNA	NULL
binding	NULL
ability	NULL
of	NULL
Stat6	NULL
was	NULL
required	NULL
for	NULL
this	NULL
effect	NULL
.	NULL

The	NULL
human	NULL
IL-4	NULL
promoter	NULL
contains	NULL
multiple	NULL
overlapping	NULL
Stat6	NULL
and	NULL
NFAT	NULL
binding	NULL
sites	NULL
.	NULL

-	NULL
The	NULL
previously	NULL
described	NULL
Stat6	NULL
binding	NULL
site	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
P2	NULL
NFAT	NULL
element	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
this	NULL
element	NULL
can	NULL
support	NULL
the	NULL
cooperative	NULL
binding	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
proteins	NULL
.	NULL
``	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
6	NULL
,	NULL
the	NULL
3'-half	NULL
of	NULL
the	NULL
Stat6	NULL
site	NULL
(	NULL
CGAA®*	NULL
)	NULL
overlaps	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
(	NULL
CGGAA®*	NULL
)	NULL
.	NULL

In	NULL
view	NULL
of	NULL
our	NULL
functional	NULL
data	NULL
showing	NULL
repression	NULL
of	NULL
a	NULL
construct	NULL
lacking	NULL
the	NULL
P2	NULL
element	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
,	NULL
we	NULL
speculated	NULL
that	NULL
Stat6	NULL
could	NULL
interact	NULL
with	NULL
additional	NULL
P	NULL
elements	NULL
from	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
ability	NULL
of	NULL
recombinant	NULL
Stat6	NULL
to	NULL
bind	NULL
similar	NULL
length	NULL
oligonucleotides	NULL
including	NULL
the	NULL
five	NULL
known	NULL
IL-4	NULL
P	NULL
elements	NULL
by	NULL
EMSA	NULL
.	NULL

Figure	NULL
7	NULL
shows	NULL
that	NULL
recombinant	NULL
Stat6	NULL
bound	NULL
30-bp	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
P1	NULL
,	NULL
P2	NULL
,	NULL
and	NULL
P4	NULL
NFAT	NULL
sites	NULL
,	NULL
but	NULL
not	NULL
the	NULL
PO	NULL
or	NULL
P3	NULL
sites	NULL
.	NULL

Based	NULL
on	NULL
sequence	NULL
homology	NULL
and	NULL
mutational	NULL
analysis	NULL
(	NULL
Fig	NULL
Stato	NULL
*	NULL
p=0.008	NULL
vs	NULL
.	NULL

Empty	NULL
Vector	NULL
with	NULL
IL-4	NULL
p=0.002	NULL
vs.	NULL
Stat6	NULL
with	NULL
no	NULL
IL-4	NULL
1	NULL
bated	NULL
without	NULL
(	NULL
0	NULL
)	NULL
or	NULL
with	NULL
(	NULL
MI	NULL
)	NULL
IL-4	NULL
(	NULL
50	NULL
ng/mL	NULL
)	NULL
for	NULL
18	NULL
hours	NULL
before	NULL
assays	NULL
for	NULL
reporter	NULL
gene	NULL
expression	NULL
by	NULL
ELISA	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
constitutive	NULL
activity	NULL
of	NULL
pCAT	NULL
265	NULL
without	NULL
IL-4	NULL
and	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

IL-4	NULL
significantly	NULL
downregulated	NULL
promoter	NULL
activity	NULL
only	NULL
in	NULL
Staté-cotransfected	NULL
cells	NULL
.	NULL

6	NULL
)	NULL
,	NULL
we	NULL
predicted	NULL
that	NULL
Stat6	NULL
and	NULL
NFAT	NULL
would	NULL
bind	NULL
competitively	NULL
to	NULL
overlapping	NULL
sites	NULL
in	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
and	NULL
to	NULL
exclude	NULL
any	NULL
combinatorial	NULL
interactions	NULL
of	NULL
these	NULL
factors	NULL
on	NULL
the	NULL
IL-4	NULL
promoter	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
effect	NULL
of	NULL
Stat6	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
NFATp	NULL
DBD	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
to	NULL
interact	NULL
with	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
P1	NULL
and	NULL
P2	NULL
elements	NULL
in	NULL
EMSA	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
NFATp	NULL
readily	NULL
bound	NULL
both	NULL
probes	NULL
(	NULL
Fig	NULL
8	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
increasing	NULL
amounts	NULL
of	NULL
Stat6	NULL
displaced	NULL
NFATp	NULL
from	NULL
its	NULL
cognate	NULL
sites	NULL
on	NULL
both	NULL
oligonucleo-tides	NULL
.	NULL

Displacement	NULL
of	NULL
NFAT	NULL
from	NULL
the	NULL
P1	NULL
element	NULL
by	NULL
Stat6	NULL
may	NULL
provide	NULL
an	NULL
explanation	NULL
for	NULL
the	NULL
repressive	NULL
effects	NULL
of	NULL
Stat6	NULL
on	NULL
pCAT	NULL
145	NULL
.	NULL

DISCUSSION	NULL
The	NULL
molecular	NULL
basis	NULL
by	NULL
which	NULL
IL-4	NULL
induces	NULL
the	NULL
production	NULL
of	NULL
Th2	NULL
cytokines	NULL
is	NULL
currently	NULL
not	NULL
known	NULL
.	NULL

Experiments	NULL
with	NULL
Stat6-deficient	NULL
mice	NULL
have	NULL
conclusively	NULL
demonstrated	NULL
a	NULL
requirement	NULL
for	NULL
this	NULL
IL-4-inducible	NULL
transcription	NULL
factor	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
into	NULL
Th2	NULL
cells	NULL
.	NULL

?	NULL

However	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
found	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
IL-4R-signaling	NULL
pathway	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
IL-4	NULL
gene	NULL
expression	NULL
in	NULL
committed	NULL
Th2	NULL
cells	NULL
.	NULL

``	NULL
®	NULL
``	NULL
``	NULL
>	NULL
4	NULL
Additionally	NULL
,	NULL
Stat6	NULL
can	NULL
repress	NULL
IL-4	NULL
gene	NULL
expression	NULL
in	NULL
Th1	NULL
cells	NULL
by	NULL
binding	NULL
a	NULL
cell-type	NULL
specific	NULL
silencer	NULL
in	NULL
the	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
(	NULL
UTR	NULL
)	NULL
.4	NULL
Thus	NULL
,	NULL
the	NULL
precise	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
regulating	NULL
IL-4	NULL
expression	NULL
is	NULL
currently	NULL
not	NULL
clear	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Stat6	NULL
INHIBITS	NULL
THE	NULL
INTERLEUKIN-4	NULL
PROMOTER	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
Stato	NULL
does	NULL
not	NULL
synergize	NULL
with	NULL
other	NULL
signals	NULL
to	NULL
activate	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

Methods	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
described	NULL
in	NULL
Fig	NULL
3	NULL
,	NULL
except	NULL
that	NULL
cells	NULL
were	NULL
also	NULL
stimulated	NULL
with	NULL
calcium	NULL
ionophore	NULL
(	NULL
§	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
M	NULL
)	NULL
,	NULL
both	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
no	NULL
agonists	NULL
(	NULL
0	NULL
)	NULL
with	NULL
or	NULL
without	NULL
IL-4	NULL
as	NULL
indicated	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
,	NULL
reporter	NULL
activity	NULL
was	NULL
consistently	NULL
decreased	NULL
in	NULL
Staté-cotransfected	NULL
cells	NULL
for	NULL
each	NULL
condition	NULL
examined	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
IL-4	NULL
almost	NULL
completely	NULL
repressed	NULL
the	NULL
promoter	NULL
.	NULL

Results	NULL
are	NULL
from	NULL
one	NULL
experiment	NULL
performed	NULL
in	NULL
duplicate	NULL
and	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
.	NULL

CAT	NULL
(	NULL
pg/ug	NULL
protein	NULL
)	NULL
600	NULL
7	NULL
5007	NULL
400	NULL
IL-4	NULL
:	NULL
4533	NULL
[	NULL
]	NULL
None	NULL
A23187	NULL
I	NULL
rma	NULL
&	NULL
A23187	NULL
+	NULL
PMA	NULL
G	NULL
§	NULL
Q	NULL
8	NULL
Y	NULL
N	NULL
§	NULL
§	NULL
y	NULL
D	NULL
8	NULL
8	NULL
&	NULL
N	NULL
&	NULL
by	NULL
Nt	NULL
h	NULL
|	NULL
xe	NULL
4	NULL
Expression	NULL
Vector	NULL
:	NULL
-	NULL
L	NULL
--	NULL
Empty	NULL
--	NULL
_	NULL
'	NULL
--	NULL
Stats	NULL
--	NULL
Th2-restricted	NULL
IL-4	NULL
gene	NULL
expression	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
controlled	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
by	NULL
the	NULL
coordinated	NULL
interactions	NULL
of	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
a	NULL
proximal	NULL
promoter	NULL
region	NULL
.	NULL

Regulatory	NULL
elements	NULL
within	NULL
the	NULL
promoter	NULL
have	NULL
been	NULL
pear	NULL
11s	NULL
:	NULL
-PI-FR	NULL
[	NULL
er	NULL
]	NULL
pCAT	NULL
265	NULL
:	NULL
28	NULL
-P1	NULL
]	NULL
-po|	NULL
shown	NULL
not	NULL
only	NULL
to	NULL
bind	NULL
nuclear	NULL
factors	NULL
unique	NULL
to	NULL
Th2	NULL
cells	NULL
,	NULL
but	NULL
also	NULL
to	NULL
be	NULL
preferentially	NULL
induced	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

*	NULL
``	NULL
``	NULL
The	NULL
observation	NULL
that	NULL
Stat6	NULL
can	NULL
interact	NULL
with	NULL
a	NULL
consensus	NULL
sequence	NULL
from	NULL
both	NULL
the	NULL
mouse	NULL
``	NULL
and	NULL
human	NULL
``	NULL
IL-4	NULL
promoters	NULL
suggested	NULL
that	NULL
this	NULL
3	NULL
[	NULL
_	NULL
]	NULL
None	NULL
»	NULL
EY	NULL
A23187	NULL
s	NULL
E	NULL
E3	NULL
a	NULL
2-	NULL
C3	NULL
fol	NULL
O94	NULL
a	NULL
£	NULL
0L	NULL
?	NULL

*	NULL
g	NULL
0	NULL
|	NULL
,	NULL
&	NULL
4.	NULL
mA	NULL
[	NULL
S	NULL
®	NULL
-	NULL
Al	NULL
ﬂ	NULL
g	NULL
0	NULL
l	NULL
Stato	NULL
wt	NULL
:	NULL
-	NULL
+	NULL
+	NULL
-	NULL
+	NULL
+	NULL
_	NULL
-	NULL
e	NULL
Stat6	NULL
DBD	NULL
mut	NULL
:	NULL
-	NULL
-	NULL
-	NULL
Lo	NULL
L	NULL
IL-4	NULL
:	NULL
-	NULL
-	NULL
+	NULL
«	NULL
o-	NULL
f	NULL
Fig	NULL
5	NULL
.	NULL

Stat6	NULL
inhibits	NULL
a	NULL
minimal	NULL
IL-4	NULL
promoter	NULL
construct	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
minimal	NULL
promoter	NULL
construct	NULL
lacking	NULL
the	NULL
known	NULL
P2	NULL
Stat6	NULL
element	NULL
(	NULL
pCAT	NULL
145	NULL
)	NULL
with	NULL
or	NULL
without	NULL
a	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
DNA-binding	NULL
domain	NULL
mutant	NULL
(	NULL
DBD	NULL
mut	NULL
)	NULL
Stat6	NULL
expression	NULL
vector	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
for	NULL
18	NULL
hours	NULL
with	NULL
calcium	NULL
ionophore	NULL
(	NULL
§	NULL
)	NULL
with	NULL
or	NULL
without	NULL
IL-4	NULL
as	NULL
indicated	NULL
,	NULL
followed	NULL
by	NULL
cell	NULL
lysis	NULL
and	NULL
analysis	NULL
of	NULL
reporter	NULL
gene	NULL
expression	NULL
by	NULL
ELISA	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
relative	NULL
to	NULL
CAT	NULL
production	NULL
in	NULL
unstimulated	NULL
cells	NULL
and	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
four	NULL
(	NULL
DBD	NULL
mut	NULL
)	NULL
or	NULL
seven	NULL
(	NULL
wt	NULL
)	NULL
independent	NULL
experiments	NULL
.	NULL

*	NULL
P	NULL
<	NULL
.05	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4534	NULL
A	NULL
NFAT	NULL
consensus	NULL
:	NULL
Human	NULL
P2	NULL
:	NULL
IgE	NULL
Stat6	NULL
:	NULL
GGAAAAT	NULL
TTCCC	NULL
AAGAA	NULL
~	NULL
»	NULL
TCTGA	NULL
TTTCA	NULL
CAGGA	NULL
ACATT	NULL
TTACC	NULL
TGTTT	NULL
'	NULL
``	NULL
~	NULL
GEORAS	NULL
ET	NULL
AL	NULL
B	NULL
Probe	NULL
:	NULL
wt	NULL
mi	NULL
m2	NULL
m3	NULL
m4	NULL
m5	NULL
m6	NULL
sec-	NULL
Wp	NULL
-_-	NULL
iy	NULL
Free	NULL
probe	NULL
:	NULL
Fig	NULL
6	NULL
.	NULL

The	NULL
P2	NULL
element	NULL
contains	NULL
overlapping	NULL
binding	NULL
sites	NULL
for	NULL
Staté	NULL
and	NULL
NFATp	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Alignment	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
P2	NULL
NFAT	NULL
element	NULL
with	NULL
canonical	NULL
binding	NULL
sites	NULL
for	NULL
NFAT	NULL
(	NULL
overline	NULL
)	NULL
and	NULL
Stat6	NULL
(	NULL
underline	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
3'-end	NULL
of	NULL
the	NULL
Stat6	NULL
sequence	NULL
overlaps	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
ability	NULL
of	NULL
recombinant	NULL
Stat6	NULL
to	NULL
interact	NULL
with	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
mutated	NULL
probes	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
w	NULL
as	NULL
determined	NULL
by	NULL
EMSA	NULL
.	NULL

Stat6	NULL
no	NULL
longer	NULL
bound	NULL
the	NULL
m2-m4	NULL
oligonucleotides	NULL
,	NULL
confirming	NULL
the	NULL
overlapping	NULL
nature	NULL
of	NULL
the	NULL
Stat6	NULL
and	NULL
NFAT	NULL
binding	NULL
sites	NULL
.	NULL

factor	NULL
might	NULL
provide	NULL
a	NULL
direct	NULL
link	NULL
between	NULL
IL-4R	NULL
activation	NULL
and	NULL
IL-4	NULL
gene	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
a	NULL
conclusion	NULL
of	NULL
our	NULL
studies	NULL
is	NULL
that	NULL
Stat6	NULL
might	NULL
only	NULL
facilitate	NULL
IL-4	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
an	NULL
indirect	NULL
fashion	NULL
.	NULL

This	NULL
report	NULL
,	NULL
showing	NULL
for	NULL
the	NULL
first	NULL
time	NULL
the	NULL
specific	NULL
effect	NULL
of	NULL
Stat6	NULL
on	NULL
the	NULL
intact	NULL
IL-4	NULL
promoter	NULL
,	NULL
contains	NULL
several	NULL
novel	NULL
observations	NULL
.	NULL

First	NULL
,	NULL
we	NULL
found	NULL
that	NULL
,	NULL
although	NULL
IL-4	NULL
receptor-mediated	NULL
signals	NULL
are	NULL
faithfully	NULL
transduced	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
,	NULL
Stat6	NULL
was	NULL
unable	NULL
to	NULL
transactivate	NULL
the	NULL
proximal	NULL
human	NULL
IL-4	NULL
promoter	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Figs	NULL
3	NULL
through	NULL
5	NULL
)	NULL
.	NULL

Together	NULL
with	NULL
previous	NULL
studies	NULL
showing	NULL
that	NULL
IL-4	NULL
can	NULL
induce	NULL
multimers	NULL
of	NULL
the	NULL
P2	NULL
Stat6	NULL
site	NULL
linked	NULL
to	NULL
heterologous	NULL
promoters	NULL
,	NULL
*	NULL
``	NULL
``	NULL
our	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
Stat6	NULL
is	NULL
dependent	NULL
on	NULL
promoter	NULL
context	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
in	NULL
keeping	NULL
A	NULL
Stat6	NULL
Probe	NULL
:	NULL
PO	NULL
P1	NULL
P2	NULL
P3	NULL
B	NULL
NFAT	NULL
PO	NULL
_	NULL
AATGTAAACTCAITT	NULL
TTCCETCGGT	NULL
TCAGC	NULL
with	NULL
recent	NULL
analyses	NULL
of	NULL
Stat6	NULL
and	NULL
the	NULL
germline	NULL
IgE	NULL
``	NULL
and	NULL
B-casein	NULL
genes	NULL
``	NULL
and	NULL
with	NULL
the	NULL
study	NULL
of	NULL
Huang	NULL
et	NULL
al	NULL
,	NULL
``	NULL
``	NULL
who	NULL
found	NULL
that	NULL
Stat6	NULL
differentially	NULL
regulated	NULL
multimers	NULL
of	NULL
the	NULL
P2	NULL
Stat6	NULL
element	NULL
in	NULL
M12	NULL
B	NULL
cells	NULL
depending	NULL
on	NULL
the	NULL
minimal	NULL
promoter	NULL
construct	NULL
used	NULL
.	NULL

Second	NULL
,	NULL
we	NULL
found	NULL
that	NULL
transcription	NULL
driven	NULL
by	NULL
two	NULL
deletion	NULL
constructs	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
promoter	NULL
was	NULL
consistently	NULL
inhibited	NULL
by	NULL
IL-4	NULL
in	NULL
Staté-expressing	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
recent	NULL
studies	NULL
suggest	NULL
that	NULL
IL-4	NULL
can	NULL
inhibit	NULL
IL-4	NULL
gene	NULL
expression	NULL
in	NULL
a	NULL
negative	NULL
feedback	NULL
fashion	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Morigg	NULL
!	NULL

et	NULL
al	NULL
``	NULL
found	NULL
that	NULL
committed	NULL
Th2	NULL
cells	NULL
secreted	NULL
more	NULL
IL-4	NULL
when	NULL
restimulated	NULL
with	NULL
anti-CD3	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
neutralizing	NULL
anti-IL-4	NULL
MoAb	NULL
.	NULL

Additionally	NULL
,	NULL
IL-4	NULL
seemed	NULL
to	NULL
inhibit	NULL
anti-CD3-induced	NULL
transcription	NULL
driven	NULL
by	NULL
the	NULL
full-length	NULL
mouse	NULL
IL-4	NULL
Fig	NULL
7	NULL
.	NULL

The	NULL
IL-4	NULL
promoter	NULL
contains	NULL
multiple	NULL
Stat6	NULL
binding	NULL
sites	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
ability	NULL
of	NULL
recombinant	NULL
Stat6	NULL
to	NULL
bind	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
human	NULL
P	NULL
ele-P4	NULL
ments	NULL
was	NULL
determined	NULL
by	NULL
EMSA	NULL
.	NULL

Stat6	NULL
bound	NULL
the	NULL
P1	NULL
,	NULL
P2	NULL
,	NULL
and	NULL
P4	NULL
probes	NULL
(	NULL
solid	NULL
arrow	NULL
)	NULL
.	NULL

An	NULL
additional	NULL
slowly	NULL
migrating	NULL
complex	NULL
(	NULL
open	NULL
arrow	NULL
)	NULL
formed	NULL
on	NULL
the	NULL
P1	NULL
oligonucleotide	NULL
(	NULL
and	NULL
occasionally	NULL
on	NULL
the	NULL
P2	NULL
probe	NULL
;	NULL
see	NULL
Fig	NULL
8	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
migration	NULL
of	NULL
the	NULL
free	NULL
probes	NULL
,	NULL
which	NULL
were	NULL
of	NULL
similar	NULL
length	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
and	NULL
radiolabeled	NULL
with	NULL
similar	NULL
specific	NULL
P3	NULL
_	NULL
AAAAAGGTTTCAITT	NULL
TTCCJTATTGG	NULL
TCTGATT	NULL
P1	NULL
_	NULL
TGGTGTAACGAAAAT	NULL
|TTCCARATGTA|	NULL
AACTCA	NULL
P4	NULL
_	NULL
AATIATGGTGTAAT	NULL
]	NULL
TTCC	NULL
[	NULL
TATGCT	NULL
|	NULL
GAACT	NULL
P2	NULL
_	NULL
AAACAGGTAAAAITG|TTCC	NULL
[	NULL
TGTGAA	NULL
|	NULL
ATCAGA	NULL
IgE	NULL
-	NULL
GTTGCTCAATCGAC|TTCCCAAGAA	NULL
|	NULL
CAG	NULL
C/EBP	NULL
Stat6	NULL
activity	NULL
,	NULL
is	NULL
not	NULL
shown	NULL
in	NULL
this	NULL
figure	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Alignment	NULL
of	NULL
the	NULL
P	NULL
elements	NULL
that	NULL
supported	NULL
Stat6	NULL
binding	NULL
with	NULL
the	NULL
composite	NULL
C/	NULL
EBP-Stat6	NULL
site	NULL
from	NULL
the	NULL
germline	NULL
IgE	NULL
promoter	NULL
.	NULL

The	NULL
P2	NULL
oligonucleotide	NULL
is	NULL
shown	NULL
in	NULL
opposite	NULL
orientation	NULL
than	NULL
in	NULL
Fig	NULL
2	NULL
.	NULL

Binding	NULL
sites	NULL
for	NULL
NFAT	NULL
,	NULL
Stat6	NULL
,	NULL
and	NULL
C/EBP	NULL
are	NULL
indicated	NULL
by	NULL
boxes	NULL
.	NULL

C/	NULL
EBP	NULL
proteins	NULL
may	NULL
interact	NULL
with	NULL
the	NULL
PO	NULL
,	NULL
P1	NULL
,	NULL
and	NULL
P4	NULL
NFAT	NULL
elements	NULL
,	NULL
although	NULL
the	NULL
precise	NULL
nucleotide	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
reported	NULL
only	NULL
for	NULL
the	NULL
P4	NULL
se-quence	NULL
.	NULL
``	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Stat6	NULL
INHIBITS	NULL
THE	NULL
INTERLEUKIN-4	NULL
PROMOTER	NULL
A	NULL
Stat6	NULL
-	NULL
»	NULL
4535	NULL
state	NULL
:	NULL
.	NULL

--	NULL
-	NULL
.	NULL

w	NULL
Una-	NULL
“	NULL
Nu	NULL
...	NULL
-	NULL
n.S	NULL
.	NULL

-im	NULL
sear	NULL
--	NULL
-Wind	NULL
hdi	NULL
bas	NULL
path	NULL
so	NULL
...	NULL
.	NULL

--	NULL
-	NULL
wnt	NULL
tnt	NULL
n	NULL
hut	NULL
put	NULL
-	NULL
P1	NULL
element	NULL
-	NULL
``	NULL
-	NULL
P2	NULL
element	NULL
1.5	NULL
1.57	NULL
B	NULL
Staté	NULL
Stato	NULL
1.07	NULL
1.0	NULL
>	NULL
--	NULL
z	NULL
W	NULL
_	NULL
os	NULL
[	NULL
--	NULL
-	NULL
o.5	NULL
C	NULL
--	NULL
-shunt	NULL
Fig	NULL
8	NULL
.	NULL

-	NULL
Stat6	NULL
binds	NULL
competitively	NULL
with	NULL
NFAT	NULL
to	NULL
the	NULL
E	NULL
v0	NULL
v.o~	NULL
P1	NULL
and	NULL
P2	NULL
elements	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
ability	NULL
of	NULL
a	NULL
recombinant	NULL
0	NULL
fragment	NULL
of	NULL
NFATp	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
to	NULL
_	NULL
>	NULL
-	NULL
'*	NULL
;	NULL
NFAT	NULL
1.0	NULL
NFAT	NULL
bind	NULL
oligonucleotide	NULL
probes	NULL
containing	NULL
the	NULL
P1	NULL
and	NULL
|	NULL
'4S	NULL
--	NULL
[	NULL
-	NULL
]	NULL
P2	NULL
elements	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentra-	NULL
5	NULL
}	NULL
08	NULL
s	NULL
08	NULL
tions	NULL
of	NULL
recombinant	NULL
Stat6	NULL
was	NULL
determined	NULL
by	NULL
EMSA	NULL
.	NULL

0	NULL
as-	NULL
os	NULL
The	NULL
relative	NULL
mobilities	NULL
of	NULL
each	NULL
factor	NULL
are	NULL
indicated	NULL
.	NULL

_	NULL
(	NULL
(	NULL
C	NULL
``	NULL
~	NULL
Serial	NULL
twofold	NULL
dilutions	NULL
of	NULL
Stat6	NULL
were	NULL
examined	NULL
0.41	NULL
0.4	NULL
against	NULL
a	NULL
constant	NULL
amount	NULL
of	NULL
NFATp	NULL
.	NULL

n.s	NULL
.	NULL

,	NULL
nonspe-cific	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
relative	NULL
intensities	NULL
of	NULL
observed	NULL
bands	NULL
0.24	NULL
0.2	NULL
were	NULL
analyzed	NULL
by	NULL
densitometry	NULL
and	NULL
expressed	NULL
relative	NULL
to	NULL
intensity	NULL
of	NULL
the	NULL
NFAT	NULL
complex	NULL
for	NULL
each	NULL
0.0	NULL
0.0	NULL
+	NULL
oligonucleotide	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Stat6	NULL
(	NULL
which	NULL
was	NULL
defined	NULL
as	NULL
1	NULL
)	NULL
.	NULL

promoter	NULL
in	NULL
a	NULL
Th2	NULL
clone	NULL
.	NULL
``	NULL

''	NULL
Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
activated	NULL
Stat6é	NULL
might	NULL
downregulate	NULL
IL-4	NULL
expression	NULL
in	NULL
effector	NULL
Th	NULL
cells	NULL
and	NULL
emphasize	NULL
the	NULL
need	NULL
to	NULL
distinguish	NULL
between	NULL
Th2	NULL
differentiation	NULL
and	NULL
IL-4	NULL
gene	NULL
expression	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
two	NULL
novel	NULL
Stat6	NULL
binding	NULL
sites	NULL
(	NULL
within	NULL
the	NULL
P1	NULL
and	NULL
P4	NULL
elements	NULL
)	NULL
in	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

Although	NULL
these	NULL
sites	NULL
do	NULL
not	NULL
contain	NULL
the	NULL
consensus	NULL
Staté	NULL
binding	NULL
site	NULL
(	NULL
5-TTCN	NULL
,	NULL
GAA-3	NULL
'	NULL
)	NULL
defined	NULL
by	NULL
binding	NULL
site	NULL
selection	NULL
assays	NULL
,	NULL
a	NULL
significant	NULL
fraction	NULL
(	NULL
10/42	NULL
)	NULL
of	NULL
sequences	NULL
selected	NULL
by	NULL
Stat6	NULL
in	NULL
these	NULL
assays	NULL
contained	NULL
single	NULL
nucleotide	NULL
substitutions	NULL
within	NULL
the	NULL
dyad	NULL
half-sites	NULL
.	NULL
``	NULL

Thus	NULL
the	NULL
ability	NULL
of	NULL
Stat6	NULL
to	NULL
bind	NULL
the	NULL
P1	NULL
oligonucleotide	NULL
(	NULL
5'-TTCN	NULL
,	NULL
GTA-3	NULL
``	NULL
)	NULL
is	NULL
not	NULL
surprising	NULL
.	NULL

The	NULL
reason	NULL
why	NULL
Stat6	NULL
bound	NULL
the	NULL
P4	NULL
element	NULL
but	NULL
not	NULL
the	NULL
PO	NULL
element	NULL
is	NULL
-_	NULL
P1	NULL
element	NULL
-	NULL
P2	NULL
element	NULL
less	NULL
apparent	NULL
,	NULL
because	NULL
they	NULL
contain	NULL
similar	NULL
noncanonical	NULL
dyad	NULL
half	NULL
sites	NULL
,	NULL
although	NULL
they	NULL
do	NULL
differ	NULL
in	NULL
the	NULL
spacer	NULL
region	NULL
.	NULL

Fourth	NULL
,	NULL
the	NULL
demonstration	NULL
that	NULL
Staté	NULL
and	NULL
NFAT	NULL
can	NULL
bind	NULL
competitively	NULL
to	NULL
the	NULL
IL-4	NULL
promoter	NULL
provides	NULL
evidence	NULL
of	NULL
a	NULL
previously	NULL
unreported	NULL
interaction	NULL
between	NULL
these	NULL
two	NULL
factors	NULL
.	NULL

Given	NULL
the	NULL
fundamental	NULL
role	NULL
of	NULL
NFAT	NULL
family	NULL
members	NULL
in	NULL
regulating	NULL
IL-4	NULL
gene	NULL
expression	NULL
,	NULL
this	NULL
observation	NULL
provides	NULL
a	NULL
plausible	NULL
explanation	NULL
for	NULL
the	NULL
observed	NULL
inhibitory	NULL
effects	NULL
of	NULL
Stat6	NULL
on	NULL
transcription	NULL
driven	NULL
by	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

This	NULL
would	NULL
be	NULL
similar	NULL
to	NULL
the	NULL
recently	NULL
described	NULL
antagonism	NULL
of	NULL
by	NULL
Stat6	NULL
in	NULL
the	NULL
E-selectin	NULL
promoter	NULL
``	NULL
Because	NULL
the	NULL
P1	NULL
element	NULL
in	NULL
particular	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
activating	NULL
IL-4	NULL
transcription	NULL
,	NULL
``	NULL
competition	NULL
by	NULL
Stat6	NULL
for	NULL
NFAT	NULL
binding	NULL
to	NULL
this	NULL
element	NULL
might	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4536	NULL
have	NULL
particularly	NULL
repressive	NULL
effects	NULL
.	NULL

Alternatively	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
Stat6é	NULL
might	NULL
actively	NULL
repress	NULL
the	NULL
basal	NULL
transcription	NULL
complex	NULL
or	NULL
that	NULL
it	NULL
might	NULL
also	NULL
bind	NULL
to	NULL
and	NULL
titrate	NULL
away	NULL
from	NULL
the	NULL
promoter	NULL
a	NULL
factor	NULL
necessary	NULL
for	NULL
maximal	NULL
IL-4	NULL
transcription	NULL
.	NULL

Stat6	NULL
might	NULL
require	NULL
a	NULL
coactivator	NULL
not	NULL
expressed	NULL
by	NULL
Jurkat	NULL
cells	NULL
to	NULL
maximally	NULL
transactivate	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Stat6	NULL
cooperates	NULL
with	NULL
both	NULL
C/EBP	NULL
and	NULL
NF-kB/Rel	NULL
proteins	NULL
``	NULL
to	NULL
promote	NULL
germline	NULL
IgE	NULL
transcription	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
C/EBP-N4	NULL
luc	NULL
is	NULL
highly	NULL
induced	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
argues	NULL
that	NULL
the	NULL
inability	NULL
of	NULL
Stat6	NULL
to	NULL
activate	NULL
IL-4	NULL
transcription	NULL
in	NULL
our	NULL
experiments	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
C/EBP	NULL
proteins	NULL
and	NULL
confirms	NULL
the	NULL
known	NULL
expression	NULL
of	NULL
C/EBP	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL
``	NULL

Additionally	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
PMA-activated	NULL
Jurkat	NULL
cells	NULL
contain	NULL
abundant	NULL
nuclear	NULL
We	NULL
can	NULL
not	NULL
formally	NULL
exclude	NULL
the	NULL
requirement	NULL
for	NULL
as	NULL
yet	NULL
unidentified	NULL
Stat6	NULL
coactivators	NULL
necessary	NULL
for	NULL
IL-4	NULL
transcription	NULL
,	NULL
although	NULL
the	NULL
studies	NULL
by	NULL
Huang	NULL
et	NULL
al	NULL
``	NULL
``	NULL
argue	NULL
against	NULL
the	NULL
existence	NULL
of	NULL
such	NULL
factors	NULL
in	NULL
a	NULL
differentiated	NULL
Th2	NULL
clone	NULL
.	NULL

Another	NULL
possibility	NULL
is	NULL
that	NULL
Stat6	NULL
might	NULL
require	NULL
additional	NULL
posttranslational	NULL
modification	NULL
to	NULL
achieve	NULL
full	NULL
transcriptional	NULL
competency	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
observations	NULL
that	NULL
(	NULL
1	NULL
)	NULL
PMA	NULL
enhanced	NULL
the	NULL
repressive	NULL
effects	NULL
of	NULL
Stat6	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
and	NULL
(	NULL
2	NULL
)	NULL
C/EBP-N4	NULL
lue	NULL
was	NULL
inducible	NULL
by	NULL
IL-4	NULL
in	NULL
Stat6-cotransfected	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
argue	NULL
against	NULL
this	NULL
explanation	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
other	NULL
factors	NULL
inhibit	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
Stat6	NULL
on	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

For	NULL
example	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
suggested	NULL
that	NULL
Bel-6	NULL
,	NULL
a	NULL
transcriptional	NULL
repressor	NULL
deregulated	NULL
in	NULL
many	NULL
lymphomas	NULL
,	NULL
``	NULL
can	NULL
specifically	NULL
inhibit	NULL
the	NULL
ability	NULL
of	NULL
Stat6	NULL
to	NULL
transactivate	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
Bcl-6-deficient	NULL
mice	NULL
were	NULL
found	NULL
to	NULL
have	NULL
enhanced	NULL
IL-4	NULL
production	NULL
and	NULL
Th2	NULL
responses	NULL
.	NULL
``	NULL

''	NULL
To	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
Bel-6	NULL
was	NULL
inhibiting	NULL
transactivation	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
by	NULL
Stat6	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
we	NULL
assayed	NULL
for	NULL
Bcl-6	NULL
binding	NULL
to	NULL
both	NULL
the	NULL
P2	NULL
element	NULL
and	NULL
a	NULL
consensus	NULL
Bel-6	NULL
site	NULL
using	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
in	NULL
EMSA	NULL
.	NULL

Using	NULL
conditions	NULL
known	NULL
to	NULL
support	NULL
Bel-6	NULL
binding	NULL
,	NULL
``	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
Bel-6	NULL
using	NULL
two	NULL
specific	NULL
antisera	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
IL-4	NULL
gene	NULL
expression	NULL
was	NULL
not	NULL
inhibited	NULL
in	NULL
Jurkat	NULL
cells	NULL
expressing	NULL
inducible	NULL
Bel-6	NULL
protein	NULL
(	NULL
Dr	NULL
Riccardo	NULL
Dalla-Favera	NULL
,	NULL
personal	NULL
communication	NULL
,	NULL
Spring	NULL
1998	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
inability	NULL
of	NULL
Stat6	NULL
to	NULL
activate	NULL
IL-4	NULL
transcription	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
specific	NULL
Stat6	NULL
antagonist	NULL
Bel-6	NULL
.	NULL

The	NULL
IL-4R	NULL
transduces	NULL
other	NULL
signals	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
Jak-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat6	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
I4R	NULL
motif	NULL
of	NULL
the	NULL
IL-4Ra	NULL
subunit	NULL
leads	NULL
to	NULL
the	NULL
IRS-1-dependent	NULL
phosphorylation	NULL
of	NULL
the	NULL
nonhistone	NULL
chromosomal	NULL
protein	NULL
HMGI/Y	NULL
.	NULL
``	NULL

'	NULL
Phosphorylation	NULL
of	NULL
HMGI/Y	NULL
in	NULL
B	NULL
cells	NULL
inhibits	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
DNA	NULL
and	NULL
results	NULL
in	NULL
the	NULL
derepression	NULL
of	NULL
germline	NULL
IgE	NULL
transcription	NULL
.	NULL
``	NULL

HMGI/Y	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
downregulate	NULL
the	NULL
IL-4	NULL
promoter	NULL
by	NULL
competing	NULL
with	NULL
NFAT	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
P1	NULL
element	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
activation	NULL
of	NULL
this	NULL
IL-4R	NULL
signaling	NULL
pathway	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
de-repress	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
our	NULL
observation	NULL
that	NULL
Stat6	NULL
also	NULL
displaces	NULL
NFAT	NULL
from	NULL
the	NULL
P1	NULL
element	NULL
(	NULL
Fig	NULL
8	NULL
)	NULL
might	NULL
explain	NULL
why	NULL
this	NULL
did	NULL
not	NULL
occur	NULL
in	NULL
our	NULL
experiments	NULL
.	NULL

It	NULL
is	NULL
worth	NULL
emphasizing	NULL
that	NULL
IL-4-dependent	NULL
differentiation	NULL
of	NULL
naive	NULL
Th	NULL
cells	NULL
into	NULL
effector	NULL
Th2	NULL
cells	NULL
involves	NULL
prolonged	NULL
GEORAS	NULL
ET	NULL
AL	NULL
exposure	NULL
to	NULL
multiple	NULL
concomitant	NULL
signals	NULL
emanating	NULL
from	NULL
the	NULL
T-cell	NULL
receptor	NULL
,	NULL
costimulatory	NULL
molecules	NULL
,	NULL
and	NULL
possibly	NULL
other	NULL
APC-derived	NULL
cytokines	NULL
.	NULL

``	NULL
*	NULL
``	NULL
°	NULL
The	NULL
precise	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
this	NULL
process	NULL
requires	NULL
further	NULL
study	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
Stat6	NULL
does	NULL
not	NULL
directly	NULL
transactivate	NULL
the	NULL
IL-4	NULL
promoter	NULL
,	NULL
which	NULL
it	NULL
actually	NULL
represses	NULL
in	NULL
cells	NULL
transcribing	NULL
the	NULL
IL-4	NULL
gene	NULL
.	NULL

Together	NULL
with	NULL
recent	NULL
analyses	NULL
of	NULL
committed	NULL
Th	NULL
cells	NULL
,	NULL
``	NULL
*	NULL
``	NULL
``	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
Stat6	NULL
may	NULL
rather	NULL
facilitate	NULL
the	NULL
acquisition	NULL
of	NULL
an	NULL
IL-4-producing	NULL
phenotype	NULL
in	NULL
differentiating	NULL
Th	NULL
cells	NULL
in	NULL
an	NULL
indirect	NULL
fashion	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
investigating	NULL
the	NULL
regulation	NULL
of	NULL
other	NULL
lineage-specific	NULL
Th2	NULL
transcription	NULL
factors	NULL
by	NULL
Staté	NULL
may	NULL
be	NULL
helpful	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
Dr	NULL
Riccardo	NULL
Dalla-Favera	NULL
for	NULL
assistance	NULL
with	NULL
the	NULL
Bcl-6	NULL
experiments	NULL
,	NULL
Dr	NULL
Anjana	NULL
Rao	NULL
for	NULL
the	NULL
NFATp	NULL
expression	NULL
vector	NULL
,	NULL
and	NULL
Dr	NULL
Marcia	NULL
Wills-Karp	NULL
(	NULL
Johns	NULL
Hopkins	NULL
University	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
)	NULL
for	NULL
helpful	NULL
suggestions	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Paul	NULL
WE	NULL
:	NULL
Interleukin-4	NULL
:	NULL
A	NULL
prototypic	NULL
immunoregulatory	NULL
lympho-kine	NULL
.	NULL

Blood	NULL
77:1859	NULL
,	NULL
1991	NULL
2	NULL
.	NULL

Del	NULL
Prete	NULL
G	NULL
,	NULL
Maggi	NULL
E	NULL
,	NULL
Parronchi	NULL
P	NULL
,	NULL
Chretien	NULL
I	NULL
,	NULL
Tiri	NULL
A	NULL
,	NULL
Macchia	NULL
D	NULL
,	NULL
Ricci	NULL
M	NULL
,	NULL
Banchereau	NULL
J	NULL
,	NULL
De	NULL
Vries	NULL
J	NULL
,	NULL
Romagnani	NULL
S	NULL
:	NULL
IL-4	NULL
is	NULL
an	NULL
essential	NULL
factor	NULL
for	NULL
the	NULL
IgE	NULL
synthesis	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
and	NULL
their	NULL
supernatants	NULL
.	NULL

J	NULL
Immunol	NULL
140:4193	NULL
,	NULL
1988	NULL
3	NULL
.	NULL

Toru	NULL
H	NULL
,	NULL
Eguchi	NULL
M	NULL
,	NULL
Matsumoto	NULL
R	NULL
,	NULL
Yanagida	NULL
M	NULL
,	NULL
Yata	NULL
J	NULL
,	NULL
Nakahata	NULL
T	NULL
:	NULL
Interleukin-4	NULL
promotes	NULL
the	NULL
development	NULL
of	NULL
tryptase	NULL
and	NULL
chymase	NULL
double-positive	NULL
human	NULL
mast	NULL
cells	NULL
accompanied	NULL
by	NULL
cell	NULL
maturation	NULL
.	NULL

Blood	NULL
91:187	NULL
,	NULL
1998	NULL
4	NULL
.	NULL

Schnyder	NULL
B	NULL
,	NULL
Lugli	NULL
S	NULL
,	NULL
Feng	NULL
N	NULL
,	NULL
Etter	NULL
H	NULL
,	NULL
Lutz	NULL
RA	NULL
,	NULL
Ryffel	NULL
B	NULL
,	NULL
Sugamura	NULL
K	NULL
,	NULL
Wunderli-Allenspach	NULL
H	NULL
,	NULL
Moser	NULL
R	NULL
:	NULL
Interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
and	NULL
IL-13	NULL
bind	NULL
to	NULL
a	NULL
shared	NULL
heterodimeric	NULL
complex	NULL
on	NULL
endothelial	NULL
cells	NULL
mediating	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
induction	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
common	NULL
y	NULL
chain	NULL
.	NULL

Blood	NULL
87:4286	NULL
,	NULL
1996	NULL
5	NULL
.	NULL

O'Garra	NULL
A	NULL
:	NULL
Cytokines	NULL
induce	NULL
the	NULL
development	NULL
of	NULL
functionally	NULL
heterogeneous	NULL
T	NULL
helper	NULL
cell	NULL
subsets	NULL
.	NULL

Immunity	NULL
8:275	NULL
,	NULL
1998	NULL
6	NULL
.	NULL

Lederer	NULL
J	NULL
,	NULL
Liou	NULL
J	NULL
,	NULL
Todd	NULL
M	NULL
,	NULL
Glimcher	NULL
L	NULL
,	NULL
Lichtman	NULL
A	NULL
:	NULL
Regulation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
helper	NULL
cell	NULL
subsets	NULL
.	NULL

J	NULL
Immunol	NULL
152:77	NULL
,	NULL
1994	NULL
7	NULL
.	NULL

Casolaro	NULL
V	NULL
,	NULL
Georas	NULL
S	NULL
,	NULL
Song	NULL
Z	NULL
,	NULL
Ono	NULL
S	NULL
:	NULL
Biology	NULL
and	NULL
genetics	NULL
of	NULL
atopic	NULL
disease	NULL
.	NULL

Curr	NULL
Opin	NULL
Immunol	NULL
8:796	NULL
,	NULL
1996	NULL
8	NULL
.	NULL

Rooney	NULL
J	NULL
,	NULL
Hoey	NULL
T	NULL
,	NULL
Glimcher	NULL
L	NULL
:	NULL
Coordinate	NULL
and	NULL
cooperative	NULL
roles	NULL
for	NULL
NF-AT	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
.	NULL

Immunity	NULL
2473	NULL
,	NULL
1995	NULL
9	NULL
.	NULL

Ho	NULL
IC	NULL
,	NULL
Hodge	NULL
MR	NULL
,	NULL
Rooney	NULL
JW	NULL
,	NULL
Glimcher	NULL
LH	NULL
:	NULL
The	NULL
proto-oncogene	NULL
c-maf	NULL
is	NULL
responsible	NULL
for	NULL
tissue-specific	NULL
expression	NULL
of	NULL
interleu-kin-4	NULL
.	NULL

Cell	NULL
85:973	NULL
,	NULL
1996	NULL
10	NULL
.	NULL

Rincon	NULL
M	NULL
,	NULL
Flavell	NULL
R	NULL
:	NULL
Transcription	NULL
mediated	NULL
by	NULL
NFAT	NULL
is	NULL
highly	NULL
inducible	NULL
in	NULL
effector	NULL
CD4+	NULL
T	NULL
helper	NULL
2	NULL
(	NULL
Th2	NULL
)	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Th1	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
17:1522	NULL
,	NULL
1997	NULL
11	NULL
.	NULL

Lederer	NULL
J	NULL
,	NULL
Perez	NULL
V	NULL
,	NULL
DesRoches	NULL
L	NULL
,	NULL
Kim	NULL
S	NULL
,	NULL
Abbas	NULL
A	NULL
,	NULL
Lichtman	NULL
A	NULL
:	NULL
Cytokine	NULL
transcriptional	NULL
events	NULL
during	NULL
helper	NULL
T	NULL
cell	NULL
subset	NULL
differentiation	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
184:397	NULL
,	NULL
1996	NULL
12	NULL
.	NULL

Li-Weber	NULL
M	NULL
,	NULL
Salgame	NULL
P	NULL
,	NULL
Hu	NULL
C	NULL
,	NULL
Davydov	NULL
I	NULL
,	NULL
Krammer	NULL
P	NULL
:	NULL
Differential	NULL
interaction	NULL
of	NULL
nuclear	NULL
factors	NULL
with	NULL
the	NULL
PRE-I	NULL
enhancer	NULL
element	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
promoter	NULL
in	NULL
different	NULL
T	NULL
cell	NULL
subsets	NULL
.	NULL

J	NULL
Immunol	NULL
158:1194	NULL
,	NULL
1997	NULL
13	NULL
.	NULL

Zheng	NULL
WP	NULL
,	NULL
Flavell	NULL
R	NULL
:	NULL
The	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
Th2	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
89:587	NULL
,	NULL
1997	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Stat6	NULL
INHIBITS	NULL
THE	NULL
INTERLEUKIN-4	NULL
PROMOTER	NULL
14	NULL
.	NULL

Szabo	NULL
S	NULL
,	NULL
Gold	NULL
J	NULL
,	NULL
Murphy	NULL
T	NULL
,	NULL
Murphy	NULL
K	NULL
:	NULL
Identification	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
controlling	NULL
interleukin-4	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
Roles	NULL
for	NULL
NF-Y	NULL
and	NULL
NF-AT	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:4793	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

Chuyvpilo	NULL
S	NULL
,	NULL
Schomberg	NULL
C	NULL
,	NULL
Gerwig	NULL
R	NULL
,	NULL
Heinfling	NULL
A	NULL
,	NULL
Reeves	NULL
R	NULL
,	NULL
Grummt	NULL
F	NULL
,	NULL
Serfling	NULL
E	NULL
:	NULL
Multiple	NULL
closely-linked	NULL
NFAT/octamer	NULL
and	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
are	NULL
part	NULL
of	NULL
the	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
21:5694	NULL
,	NULL
1993	NULL
16	NULL
.	NULL

Ranger	NULL
A	NULL
,	NULL
Hodge	NULL
M	NULL
,	NULL
Gravallese	NULL
E	NULL
,	NULL
Oukka	NULL
M	NULL
,	NULL
Davidson	NULL
L	NULL
,	NULL
Alt	NULL
F	NULL
,	NULL
de	NULL
la	NULL
Brousse	NULL
F	NULL
,	NULL
Hoey	NULL
T	NULL
,	NULL
Grusby	NULL
M	NULL
,	NULL
Glimcher	NULL
L	NULL
:	NULL
Delayed	NULL
lymphoid	NULL
repopulation	NULL
with	NULL
defects	NULL
in	NULL
IL-4-driven	NULL
responses	NULL
produced	NULL
by	NULL
inactivation	NULL
of	NULL
NF-ATc	NULL
.	NULL

Immunity	NULL
8:125	NULL
,	NULL
1998	NULL
17	NULL
.	NULL

Yoshida	NULL
H	NULL
,	NULL
Nishina	NULL
H	NULL
,	NULL
Takimoto	NULL
H	NULL
,	NULL
Marengére	NULL
L	NULL
,	NULL
Wakeham	NULL
A	NULL
,	NULL
Bouchard	NULL
D	NULL
,	NULL
Kong	NULL
Y-Y	NULL
,	NULL
Ohteki	NULL
T	NULL
,	NULL
Shahinian	NULL
A	NULL
,	NULL
Bacjmann	NULL
M	NULL
,	NULL
Ohashi	NULL
P	NULL
,	NULL
Penninger	NULL
J	NULL
,	NULL
Crabtree	NULL
G	NULL
,	NULL
Mak	NULL
TW	NULL
:	NULL
The	NULL
transcription	NULL
factot	NULL
NF-ATc1	NULL
regulates	NULL
lymphocyte	NULL
proliferation	NULL
and	NULL
Th2	NULL
cytokine	NULL
production	NULL
.	NULL

Immunity	NULL
8:115	NULL
,	NULL
1998	NULL
18	NULL
.	NULL

Viola	NULL
JP	NULL
,	NULL
Kiani	NULL
A	NULL
,	NULL
Bozza	NULL
PT	NULL
,	NULL
Rao	NULL
A	NULL
:	NULL
Regulation	NULL
of	NULL
allergic	NULL
inflammation	NULL
and	NULL
eosinophil	NULL
recruitment	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
:	NULL
Role	NULL
of	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
and	NULL
IL-5	NULL
.	NULL

Blood	NULL
91:2223	NULL
,	NULL
1998	NULL
19	NULL
.	NULL

Ryan	NULL
J	NULL
:	NULL
Interleukin-4	NULL
and	NULL
its	NULL
receptor	NULL
:	NULL
Essential	NULL
mediators	NULL
of	NULL
the	NULL
allergic	NULL
response	NULL
.	NULL

J	NULL
Allergy	NULL
Clin	NULL
Immunol	NULL
99:1	NULL
,	NULL
1997	NULL
20	NULL
.	NULL

Reichel	NULL
M	NULL
,	NULL
Nelson	NULL
BH	NULL
,	NULL
Greenberg	NULL
PD	NULL
,	NULL
Rothman	NULL
PB	NULL
:	NULL
The	NULL
IL-4	NULL
receptor	NULL
alpha-chain	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
sufficient	NULL
for	NULL
activation	NULL
of	NULL
JAK-1	NULL
and	NULL
STAT6	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
IL-4-specific	NULL
gene	NULL
expression	NULL
.	NULL

J	NULL
Immunol	NULL
158:5860	NULL
,	NULL
1997	NULL
21	NULL
.	NULL

Mikita	NULL
T	NULL
,	NULL
Campbell	NULL
D	NULL
,	NULL
Wu	NULL
P	NULL
,	NULL
Williamson	NULL
K	NULL
,	NULL
Schindler	NULL
U	NULL
:	NULL
Requirements	NULL
for	NULL
interleukin-4-induced	NULL
gene	NULL
expression	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
Stat6	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
16:5811	NULL
,	NULL
1996	NULL
22	NULL
.	NULL

Kotanides	NULL
H	NULL
,	NULL
Reich	NULL
NC	NULL
:	NULL
Interleukin-4-induced	NULL
STAT6	NULL
recognizes	NULL
and	NULL
activates	NULL
a	NULL
target	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
interleukin-4	NULL
receptor	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
271:25555	NULL
,	NULL
1996	NULL
23	NULL
.	NULL

Kaplan	NULL
MH	NULL
,	NULL
Schindler	NULL
U	NULL
,	NULL
Smiley	NULL
ST	NULL
,	NULL
Grusby	NULL
MJ	NULL
:	NULL
Stat6	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
responses	NULL
to	NULL
IL-4	NULL
and	NULL
for	NULL
development	NULL
of	NULL
Th2	NULL
cells	NULL
.	NULL

Immunity	NULL
4:313	NULL
,	NULL
1996	NULL
24	NULL
.	NULL

Shimoda	NULL
K	NULL
,	NULL
van	NULL
Deursen	NULL
J	NULL
,	NULL
Sangster	NULL
MY	NULL
,	NULL
Sarawar	NULL
SR	NULL
,	NULL
Carson	NULL
RT	NULL
,	NULL
Tripp	NULL
RA	NULL
,	NULL
Chu	NULL
C	NULL
,	NULL
Quelle	NULL
FW	NULL
,	NULL
Nosaka	NULL
T	NULL
,	NULL
Vignali	NULL
DA	NULL
,	NULL
Doherty	NULL
PC	NULL
,	NULL
Grosveld	NULL
G	NULL
,	NULL
Paul	NULL
WE	NULL
,	NULL
Thie	NULL
JN	NULL
:	NULL
Lack	NULL
of	NULL
IL-4-induced	NULL
Th2	NULL
response	NULL
and	NULL
IgE	NULL
class	NULL
switching	NULL
in	NULL
mice	NULL
with	NULL
disrupted	NULL
Stat6	NULL
gene	NULL
.	NULL

Nature	NULL
380:630	NULL
,	NULL
1996	NULL
25	NULL
.	NULL

Takeda	NULL
K	NULL
,	NULL
Tanaka	NULL
T	NULL
,	NULL
Shi	NULL
W	NULL
,	NULL
Matsumoto	NULL
M	NULL
,	NULL
Minami	NULL
M	NULL
,	NULL
Kashiwamura	NULL
S	NULL
,	NULL
Nakanishi	NULL
K	NULL
,	NULL
Yoshida	NULL
N	NULL
,	NULL
Kishimoto	NULL
T	NULL
,	NULL
Akira	NULL
S	NULL
:	NULL
Essential	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
IL-4	NULL
signalling	NULL
.	NULL

Nature	NULL
380:627	NULL
,	NULL
1996	NULL
26	NULL
.	NULL

Curiel	NULL
C	NULL
,	NULL
Lahesman	NULL
R	NULL
,	NULL
Subleski	NULL
J	NULL
,	NULL
Cippitelli	NULL
M	NULL
,	NULL
Kirken	NULL
RA	NULL
,	NULL
Young	NULL
HA	NULL
,	NULL
Ghosh	NULL
P	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
Stat6-responsive	NULL
element	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
interleukin-4	NULL
gene	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
27:1982	NULL
,	NULL
1997	NULL
27	NULL
.	NULL

Cumberland	NULL
J	NULL
,	NULL
Burke	NULL
T	NULL
,	NULL
Casolaro	NULL
V	NULL
,	NULL
Chen	NULL
R	NULL
,	NULL
Georas	NULL
S	NULL
:	NULL
Multiple	NULL
Stat6	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Am	NULL
J	NULL
Resp	NULL
Crit	NULL
Care	NULL
Med	NULL
156	NULL
:	NULL
A697	NULL
,	NULL
1997	NULL
(	NULL
abstr	NULL
)	NULL
28	NULL
.	NULL

Huang	NULL
H	NULL
,	NULL
Hu-Li	NULL
J	NULL
,	NULL
Chen	NULL
H	NULL
,	NULL
Ben-Sasson	NULL
SZ	NULL
,	NULL
Paul	NULL
W	NULL
:	NULL
IL-4	NULL
and	NULL
IL-13	NULL
Production	NULL
in	NULL
differentiated	NULL
T	NULL
helper	NULL
type	NULL
2	NULL
cells	NULL
is	NULL
not	NULL
IL-4	NULL
dependent	NULL
.	NULL

J	NULL
Immunol	NULL
159:3731	NULL
,	NULL
1997	NULL
29	NULL
.	NULL

Morigg	NULL
!	NULL

R	NULL
,	NULL
Kristofic	NULL
C	NULL
,	NULL
Kinzel	NULL
B	NULL
,	NULL
Volarevic	NULL
S	NULL
,	NULL
Groner	NULL
B	NULL
,	NULL
Brinkmann	NULL
V	NULL
:	NULL
Activation	NULL
of	NULL
STAT	NULL
proteins	NULL
and	NULL
cytokine	NULL
genes	NULL
in	NULL
human	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
generated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-12	NULL
and	NULL
IL-4	NULL
.	NULL

J	NULL
Immunol	NULL
160:3385	NULL
,	NULL
1998	NULL
30	NULL
.	NULL

Otsuka	NULL
T	NULL
,	NULL
Villaret	NULL
D	NULL
,	NULL
Yokota	NULL
T	NULL
,	NULL
Takebe	NULL
Y	NULL
,	NULL
Lee	NULL
F	NULL
,	NULL
Arai	NULL
N	NULL
,	NULL
Arai	NULL
K	NULL
:	NULL
Structural	NULL
analysis	NULL
of	NULL
the	NULL
mouse	NULL
chromosomal	NULL
gene	NULL
encoding	NULL
interleukin	NULL
4	NULL
which	NULL
expresses	NULL
B	NULL
cell	NULL
,	NULL
T	NULL
cell	NULL
and	NULL
mast	NULL
cell	NULL
stimulating	NULL
activities	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
15:333	NULL
,	NULL
1987	NULL
31	NULL
.	NULL

Li-Weber	NULL
M	NULL
,	NULL
Eder	NULL
A	NULL
,	NULL
Krafft-Czepa	NULL
H	NULL
,	NULL
Krammer	NULL
P	NULL
:	NULL
T	NULL
cell-specific	NULL
negative	NULL
regulation	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
cytokine	NULL
IL-4	NULL
.	NULL

J	NULL
Immunol	NULL
148:1913	NULL
,	NULL
1992	NULL
4537	NULL
32	NULL
.	NULL

Chang	NULL
C	NULL
,	NULL
Ye	NULL
B	NULL
,	NULL
Chagant	NULL
R	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Bcl-6	NULL
,	NULL
a	NULL
POZ/zinc-finger	NULL
protein	NULL
,	NULL
is	NULL
a	NULL
sequence-specific	NULL
transcriptional	NULL
repressor	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93:6947	NULL
,	NULL
1996	NULL
33	NULL
.	NULL

Schreiber	NULL
E	NULL
,	NULL
Matthias	NULL
P	NULL
,	NULL
Miiller	NULL
M	NULL
,	NULL
Schaffner	NULL
W	NULL
:	NULL
Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
mini-extracts	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
17:6419	NULL
,	NULL
1989	NULL
34	NULL
.	NULL

Rao	NULL
A	NULL
,	NULL
Luo	NULL
C	NULL
,	NULL
Hogan	NULL
P	NULL
:	NULL
Transcription	NULL
factors	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
:	NULL
Regulation	NULL
and	NULL
function	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
15:707	NULL
,	NULL
1997	NULL
35	NULL
.	NULL

Jain	NULL
J	NULL
,	NULL
Burgeon	NULL
E	NULL
,	NULL
Badalian	NULL
T	NULL
,	NULL
Hogan	NULL
P	NULL
,	NULL
Rao	NULL
A	NULL
:	NULL
A	NULL
similar	NULL
DNA-binding	NULL
Motif	NULL
in	NULL
NFAT	NULL
family	NULL
proteins	NULL
and	NULL
the	NULL
rel	NULL
homology	NULL
region	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:4138	NULL
,	NULL
1995	NULL
36	NULL
.	NULL

Davydov	NULL
I	NULL
,	NULL
Krammer	NULL
P	NULL
,	NULL
Li-Weber	NULL
M	NULL
:	NULL
Nuclear	NULL
factor-IL-6	NULL
activates	NULL
the	NULL
human	NULL
IL-4	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
155:5273	NULL
,	NULL
1995	NULL
37	NULL
.	NULL

Casolaro	NULL
V	NULL
,	NULL
Georas	NULL
S	NULL
,	NULL
Song	NULL
Z	NULL
,	NULL
Zubkoff	NULL
I	NULL
,	NULL
Abdulkadir	NULL
S	NULL
,	NULL
Thanos	NULL
D	NULL
,	NULL
Ono	NULL
S	NULL
:	NULL
Inhibition	NULL
of	NULL
NF-AT-dependent	NULL
transcription	NULL
by	NULL
NF-kB	NULL
:	NULL
Implications	NULL
for	NULL
differential	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

Proc	NULL
Nat	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:11623	NULL
,	NULL
1995	NULL
38	NULL
.	NULL

Paliogianni	NULL
F	NULL
,	NULL
Hama	NULL
N	NULL
,	NULL
Mavrothalassitis	NULL
GJ	NULL
,	NULL
Thyphronitis	NULL
G	NULL
,	NULL
Boumpas	NULL
DT	NULL
:	NULL
Signal	NULL
requirements	NULL
for	NULL
interleukin	NULL
4	NULL
promoter	NULL
activation	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
Immunol	NULL
168:33	NULL
,	NULL
1996	NULL
39	NULL
.	NULL

Burke	NULL
T	NULL
,	NULL
Cumberland	NULL
J	NULL
,	NULL
Chen	NULL
R	NULL
,	NULL
Casolaro	NULL
V	NULL
,	NULL
Georas	NULL
S	NULL
:	NULL
NFAT/AP-1	NULL
interactions	NULL
on	NULL
the	NULL
human	NULL
IL-4	NULL
promoter	NULL
'	NULL
P	NULL
'	NULL
elements	NULL
and	NULL
description	NULL
of	NULL
a	NULL
novel	NULL
NFAT	NULL
binding	NULL
site	NULL
.	NULL

Am	NULL
J	NULL
Respir	NULL
Crit	NULL
Care	NULL
Med	NULL
155	NULL
:	NULL
A697	NULL
,	NULL
1997	NULL
(	NULL
abstr	NULL
)	NULL
40	NULL
.	NULL

Li-Weber	NULL
M	NULL
,	NULL
Salgame	NULL
P	NULL
,	NULL
Hu	NULL
C	NULL
,	NULL
Krammer	NULL
PH	NULL
:	NULL
Characterization	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
P2	NULL
NE-AT	NULL
site	NULL
in	NULL
the	NULL
human	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Gene	NULL
188:253	NULL
,	NULL
1997	NULL
41	NULL
.	NULL

Morris	NULL
SC	NULL
,	NULL
Coffman	NULL
RL	NULL
,	NULL
Finkelman	NULL
FD	NULL
:	NULL
In	NULL
vivo	NULL
IL-4	NULL
responses	NULL
to	NULL
anti-IgD	NULL
antibody	NULL
are	NULL
MHC	NULL
class	NULL
II	NULL
dependent	NULL
and	NULL
beta	NULL
2-microglobu-lin	NULL
independent	NULL
and	NULL
develop	NULL
normally	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-4	NULL
priming	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
160:3299	NULL
,	NULL
1998	NULL
42	NULL
.	NULL

Kubo	NULL
M	NULL
,	NULL
Ransom	NULL
J	NULL
,	NULL
Webb	NULL
D	NULL
,	NULL
Hashimoto	NULL
Y	NULL
,	NULL
Tada	NULL
T	NULL
,	NULL
Nakayama	NULL
T	NULL
:	NULL
T-cell	NULL
subset-specific	NULL
expression	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
silencer	NULL
element	NULL
and	NULL
STAT6	NULL
.	NULL

EMBO	NULL
J	NULL
16:4007	NULL
,	NULL
1997	NULL
43	NULL
.	NULL

Wang	NULL
DZ	NULL
,	NULL
Cherrington	NULL
A	NULL
,	NULL
Famakin-Mosuro	NULL
N	NULL
,	NULL
Boothby	NULL
M	NULL
:	NULL
Independent	NULL
pathways	NULL
for	NULL
de-repression	NULL
of	NULL
the	NULL
mouse	NULL
Ig	NULL
heavy	NULL
chain	NULL
germ-line	NULL
epsilon	NULL
promoter	NULL
:	NULL
An	NULL
IL-4	NULL
NAF/NF-IL-4	NULL
site	NULL
as	NULL
a	NULL
context-dependent	NULL
negative	NULL
element	NULL
.	NULL

Int	NULL
Immunol	NULL
8:977	NULL
,	NULL
1996	NULL
44	NULL
.	NULL

Morigg	NULL
!	NULL

R	NULL
,	NULL
Berchtold	NULL
S	NULL
,	NULL
Friedrich	NULL
K	NULL
,	NULL
Standke	NULL
G	NULL
,	NULL
Kammer	NULL
W	NULL
,	NULL
Hejm	NULL
M	NULL
,	NULL
Wissler	NULL
M	NULL
,	NULL
Stiocklin	NULL
E	NULL
,	NULL
Gouilleux	NULL
F	NULL
,	NULL
Groner	NULL
B	NULL
:	NULL
Comparison	NULL
of	NULL
the	NULL
transactivation	NULL
domains	NULL
of	NULL
Stat	NULL
and	NULL
Stat6	NULL
in	NULL
lymphoid	NULL
cells	NULL
and	NULL
mammary	NULL
epithelial	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
17:3663	NULL
,	NULL
1997	NULL
45	NULL
.	NULL

Schindler	NULL
U	NULL
,	NULL
Wu	NULL
P	NULL
,	NULL
Rithe	NULL
M	NULL
,	NULL
Brasseur	NULL
M	NULL
,	NULL
McKnight	NULL
S	NULL
:	NULL
Components	NULL
of	NULL
a	NULL
Stat	NULL
recognition	NULL
code	NULL
:	NULL
Evidence	NULL
for	NULL
two	NULL
layers	NULL
of	NULL
molecular	NULL
selectivity	NULL
.	NULL

Immunity	NULL
2:689	NULL
,	NULL
1995	NULL
46	NULL
.	NULL

Bennet	NULL
B	NULL
,	NULL
Cruz	NULL
R	NULL
,	NULL
Lacson	NULL
R	NULL
,	NULL
Manning	NULL
A	NULL
:	NULL
Interleukin-4	NULL
supres-sion	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha-stimulated	NULL
E-selectin	NULL
gene	NULL
transcription	NULL
is	NULL
mediated	NULL
by	NULL
Stat6	NULL
antagonism	NULL
of	NULL
NF-kappaB	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
272:10212	NULL
,	NULL
1997	NULL
47	NULL
.	NULL

Tara	NULL
D	NULL
,	NULL
Weiss	NULL
D	NULL
,	NULL
Brown	NULL
M	NULL
:	NULL
An	NULL
activation-responsive	NULL
element	NULL
in	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
is	NULL
the	NULL
site	NULL
of	NULL
an	NULL
inducible	NULL
DNA-protein	NULL
interac-tion	NULL
.	NULL

J	NULL
Immunol	NULL
151:3617	NULL
,	NULL
1993	NULL
48	NULL
.	NULL

Messner	NULL
B	NULL
,	NULL
Stutz	NULL
AM	NULL
,	NULL
Albrecht	NULL
B	NULL
,	NULL
Peiritsch	NULL
S	NULL
,	NULL
Woisetschlager	NULL
M	NULL
:	NULL
Cooperation	NULL
of	NULL
binding	NULL
sites	NULL
for	NULL
STAT6	NULL
and	NULL
NF	NULL
kappa	NULL
B/rel	NULL
in	NULL
the	NULL
IL-4-induced	NULL
up-regulation	NULL
of	NULL
the	NULL
human	NULL
IgE	NULL
germline	NULL
promoter	NULL
.	NULL

J	NULL
Immunol	NULL
159:3330	NULL
,	NULL
1997	NULL
49	NULL
.	NULL

Chen	NULL
W	NULL
,	NULL
Iida	NULL
S	NULL
,	NULL
Louie	NULL
DC	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
,	NULL
Chaganti	NULL
RS	NULL
:	NULL
Heterologous	NULL
promoters	NULL
fused	NULL
to	NULL
BCL6	NULL
by	NULL
chromosomal	NULL
translocations	NULL
affecting	NULL
band	NULL
3q27	NULL
cause	NULL
its	NULL
deregulated	NULL
expression	NULL
during	NULL
B-cell	NULL
differentiation	NULL
.	NULL

Blood	NULL
91:603	NULL
,	NULL
1998	NULL
50	NULL
.	NULL

Dent	NULL
A	NULL
,	NULL
Shaffer	NULL
A	NULL
,	NULL
Yu	NULL
X	NULL
,	NULL
Allman	NULL
D	NULL
,	NULL
Staudt	NULL
L	NULL
:	NULL
Control	NULL
of	NULL
inflammation	NULL
,	NULL
cytokine	NULL
expression	NULL
,	NULL
and	NULL
germinal	NULL
center	NULL
formation	NULL
by	NULL
Bel-6	NULL
.	NULL

Science	NULL
276:589	NULL
,	NULL
1997	NULL
51	NULL
.	NULL

Wang	NULL
D	NULL
,	NULL
Zamorano	NULL
J	NULL
,	NULL
Keegan	NULL
A	NULL
,	NULL
Boothby	NULL
M	NULL
:	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4538	NULL
phosphorylation	NULL
status	NULL
as	NULL
a	NULL
nuclear	NULL
target	NULL
regulated	NULL
through	NULL
insulin	NULL
receptor	NULL
substrate-1	NULL
and	NULL
the	NULL
I4R	NULL
motif	NULL
of	NULL
the	NULL
interleukin-4	NULL
receptor	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
272:25083	NULL
,	NULL
1997	NULL
52	NULL
.	NULL

Wang	NULL
D	NULL
,	NULL
Ray	NULL
P	NULL
,	NULL
Boothby	NULL
M	NULL
:	NULL
Rapamycin	NULL
inhibits	NULL
interleukin	NULL
4-inducible	NULL
phosphorylation	NULL
of	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:22924	NULL
,	NULL
1995	NULL
53	NULL
.	NULL

Klein-Hessling	NULL
S	NULL
,	NULL
Schneider	NULL
G	NULL
,	NULL
Heinfling	NULL
A	NULL
,	NULL
Chuvpillo	NULL
S	NULL
,	NULL
Serfling	NULL
E	NULL
:	NULL
HMGI	NULL
(	NULL
Y	NULL
)	NULL
interferes	NULL
with	NULL
DNA	NULL
binding	NULL
of	NULL
NF-AT	NULL
factors	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
interleukin	NULL
4	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93:15311	NULL
,	NULL
1996	NULL
GEORAS	NULL
ET	NULL
AL	NULL
54	NULL
.	NULL

Constant	NULL
SL	NULL
,	NULL
Bottomly	NULL
K	NULL
:	NULL
Induction	NULL
of	NULL
Th1	NULL
and	NULL
Th2	NULL
CD4+	NULL
T	NULL
cell	NULL
responses	NULL
:	NULL
The	NULL
alternative	NULL
approaches	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
15:297	NULL
,	NULL
1997	NULL
55	NULL
.	NULL

Brinkmann	NULL
V	NULL
,	NULL
Kinzel	NULL
B	NULL
,	NULL
Kristofic	NULL
C	NULL
:	NULL
TCR-independent	NULL
activation	NULL
of	NULL
human	NULL
CD4+	NULL
45RO-T	NULL
cells	NULL
by	NULL
anti-€CD28	NULL
plus	NULL
IL-2	NULL
:	NULL
Induction	NULL
of	NULL
clonal	NULL
expansion	NULL
and	NULL
priming	NULL
for	NULL
a	NULL
Th2	NULL
phenotype	NULL
.	NULL

J	NULL
Immunol	NULL
156:4100	NULL
,	NULL
1996	NULL
56	NULL
.	NULL

Rincon	NULL
M	NULL
,	NULL
Aunguita	NULL
J	NULL
,	NULL
Nakamura	NULL
T	NULL
,	NULL
Fikrig	NULL
E	NULL
,	NULL
Flavell	NULL
RA	NULL
:	NULL
Interleukin	NULL
(	NULL
IL	NULL
)	NULL
-6	NULL
directs	NULL
the	NULL
differentiation	NULL
of	NULL
IL-4-producing	NULL
CD4+	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
185:461	NULL
,	NULL
1997	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1998	NULL
92	NULL
:	NULL
45290-4538	NULL
Stat6	NULL
Inhibits	NULL
Human	NULL
Interleukin-4	NULL
Promoter	NULL
Activity	NULL
in	NULL
T	NULL
Cells	NULL
4	NULL
peRiCAy	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
Steve	NULL
N.	NULL
Georas	NULL
,	NULL
John	NULL
E.	NULL
Cumberland	NULL
,	NULL
Thomas	NULL
F.	NULL
Burke	NULL
,	NULL
Rongbing	NULL
Chen	NULL
,	NULL
Ulrike	NULL
Schindler	NULL
and	NULL
Vincenzo	NULL
Casolaro	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/92/12/4529.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

